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The quest for innovations that can maximize the curative potential of radiation therapy while 
minimizing harmful dose to critical organs has been an active research topic for over 100 years. In 
recent decades, adaptive radiotherapy (ART) has been recognized as an important step towards 
realizing this goal. ART refers to the modification of treatment plans in response to patient 
changes, such as weight-loss, tumor shrinkage, or daily anatomical variations over the course of 
treatment. The rationale for adaptive radiotherapy is that as patients (who typically undergo weeks 
of fractionated treatment) experience geometric or anatomical changes near the tumor site, the 
parameters of their treatment plan (defined by a computed tomography [CT]) simulation taken 
prior to the start of treatment) may no longer provide adequate target coverage or normal tissue 
sparing days or weeks later. This dissertation explores the novel application of quantum physics 
principles and deep machine learning techniques to address three challenges towards the clinical 
implementation of ART: (1) efficient calculation of optimal treatment parameters, (2) adaptation 
to geometrical changes over the treatment period while mitigating associated uncertainties, and (3) 
understanding the relationship between individual patient characteristics and clinical outcomes. 
Applications of quantum and machine learning modeling in other fields support the potential of 
this novel, interdisciplinary approach. 
For efficient optimization, we developed and tested a quantum-inspired, stochastic algorithm 
for intensity-modulated radiotherapy (IMRT): quantum tunnel annealing (QTA). By modeling the 
likelihood probability of accepting a higher energy solution after a particle tunneling through a 
potential energy barrier, QTA features an additional degree of freedom (the barrier width, w) not 
 xviii 
shared by traditional stochastic optimization methods such as simulated annealing (SA). QTA was 
validated on two liver cancer patients for beamlet weight optimization for IMRT and direct 
aperture optimization for volumetric arc therapy. QTA was found to achieve convergence up to 
46.6% (26.8%) faster than SA for beamlet-weight optimization and direct aperture optimization, 
respectively. The results of this study suggest that the additional degree of freedom provided by 
QTA can improve convergence rates and achieve a more efficient and, potentially, effective 
treatment planning process. 
  For geometrical adaptation, we investigated the feasibility of predicting patient changes 
across a fractionated treatment schedule using two approaches. The first was based on a joint 
framework (referred to as QRNN) employing quantum mechanics in combination with deep 
recurrent neural networks (RNNs). The second approach was developed based on a classical 
framework (MRNN), which modelled patient anatomical changes as a Markov process. We 
evaluated and compared these two approaches’ performance characteristics using a dataset of 125 
head and neck cancer patients who received radiotherapy as part of their treatment and had daily 
cone-beam CT (CBCT) imaging. The MRNN framework was found to have slightly better 
performance than the QRNN framework, with MRNN(QRNN) validation area under the receiver 
operating characteristic curve (AUC) scores (± 95% confidence interval) of 0.742 ± 0.021 (0.675 
± 0.036), 0.709 ± 0.026 (0.656 ± 0.021), 0.724 ± 0.036 (0.652 ± 0.044), and 0.698 ± 0.016 (0.605 
± 0.035) for system state vector sizes of 4, 6, 8, and 10, respectively. Of these, only the results 
from the two higher order states were found to have statistically significant differences (p<0.05). 
A similar trend was also observed when the fully trained models were applied to an external testing 
dataset of 20 patients, yielding MRNN(QRNN) AUC scores of 0.707 (0.623), 0.687 (0.608), 0.723 
(0.669), and 0.697 (0.609) for states vectors sizes of 4, 6, 8, and 10, respectively. These results 
 xix 
suggest that these stochastic models provide added value in predicting patient changes during the 
course of adaptive radiotherapy.  
Towards understanding the relationship between patient characteristics and clinical outcomes, 
we performed a series of studies which investigated the use of quantitative patient features for 
predicting clinical outcomes in laryngeal cancer patients who underwent treatment in a 
bioselection paradigm based on surgeon-assessed response to induction chemotherapy. Among the 
features investigated from CT scans taken before and after induction chemotherapy, two (gross 
tumor volume change between pre- and post-induction chemotherapy, and nodal stage) had 
prognostic value for predicting patient outcomes using standard regression models. Artificial 
neural networks did not improve predictive performance in this case. 
Taken together, the significance of these studies lies in their contribution to the body of 
knowledge of medical physics and in their demonstration of the use of novel techniques which 
incorporate quantum mechanics and machine learning as a joint framework for treatment planning 




Chapter 1 Introduction 
 
 
“Nothing is too wonderful to be true, if it be consistent with the laws of nature” 
– Michael Faraday 
 
1.1 Adaptive Radiotherapy 
Adaptive radiotherapy (ART) refers to a radiation therapy treatment regimen in which a patient’s 
treatment plan is modified mid-treatment in response to measurements on relevant patient features. 
Adaptive radiotherapy is an attractive alternative to standard radiotherapy, in which the treatment 
plan remains static over the entire course of treatment, because patients do not remain static with 
respect to the medical images used to design their treatment plans. Over the course of treatment, 
patients may experience anatomical variations such as tumor shrinkage or weight loss, posture and 
daily setup variations, as well as anatomical changes due to bodily functions such as respiration or 
digestion.1 These changes in the “state” of the patient represent an uncertainty in tumor coverage 
which traditionally has been handled by adding a margin around the clinical target volume (CTV) 
to create the planning target volume (PTV). ART promises to provide a personalized approach 
handling anatomical variations which provides greater tumor coverage and sparing of normal 
tissues. 
Since its inception in the late 1990s, much progress has been made towards the 
implementation of adaptive radiotherapy.2 Advancements in imaging such as the development of 
 2 
cone-beam computed tomography (CBCT) have allowed for standard use of daily on-board 
imaging, in which the patient is imaged directly from the treatment couch either immediately 
before or during treatment. The use of daily imaging allows for the opportunity to perform image-
guided adaptive radiotherapy, in which daily imaging is used to inform necessary treatment 
modifications. In addition, many studies have sought to address questions such as: 1) what are the 
expected margins of anatomical variation during treatment,3-8 2) how much do such variations 
result in dose deviations from the original treatment plan,9 and 3) what are the potential clinical 
impacts of such deviations?10 Finally, studies have also presented predictive frameworks to 
identify patients who would benefit from ART based on expected anatomical or dosimetric 
changes.11  
Nevertheless, many challenges still remain for broad implementation of ART in the clinical 
environment. Because treatment plan design and optimization are time-consuming and resource-
intensive processes, efficient and robust optimization algorithms are necessary for plan adaptations 
to be feasible under the constraints of a busy clinical environment. In addition, there is still room 
for the development of improved predictive frameworks which can pre-emptively identify which 
patients are likely to experience significant anatomical changes during the course of their 
treatment, and such frameworks need to be robust to uncertainties related to CBCT image quality 
and restricted field of view. Finally, there is a general lack of consensus among the radiation 
oncology community regarding what kinds of patient changes or features that should be utilized 
for guiding adaptive radiotherapy.12 Further work is therefore necessary to better understand how 
individual patient characteristics and anatomical changes can relate to meaningful clinical 
outcomes such as survival or radiation-induced toxicity. The studies presented in this dissertation 
 3 
seek to provide additional tools and insights to address these challenges, especially in the most 
common geometrical deformations that may impact the quality of the delivered radiotherapy. 
1.2 Machine Learning and Deep Learning 
Machine learning refers to data-driven algorithms which use observations in a training dataset to 
learn a functional mapping from inputs to desired outputs (labels). Deep learning refers to a 
subclass of machine learning algorithms that are capable of learning higher order representations 
of data through the application of multiple layers on non-linear operations performed on the input 
data.  
The foundational groundwork for deep learning was laid decades prior to its rise in 
popularity: first in the 1950s when Rosenblatt introduced the concept of the perceptron (a precursor 
to the hidden nodes in today’s neural networks) and later in the 1980s with Hinton and Sejnowski’s 
invention of the Boltzmann Machine (a multilayer network similar in design to modern neural 
networks).13,14 However, for several decades deep learning methods were not viable for solving 
real-world problems. This was partly due to limitations on the computer processing power 
necessary to train the multi-layer networks envisioned by deep learning researchers and also due 
to the need for further algorithmic innovations (such as dropout and stochastic optimization 
schemes) to improve training efficiency. By the early 2010s, such discoveries, in combination with 
improvements in computer parallel processing power and graphics processing units (GPUs), 
helped to provide the necessary conditions for deep learning methods to achieve widespread 
success and recognition. This phenomenon arguably began with the startling 2012 victory in the 
ImageNet competition (an annual image classification challenge which sets the bar for the state-
of-the art in computer vision) with AlexNet: a deep convolutional neural network architecture.15 
Deep learning has since been applied with great success to many diverse challenges, including 
 4 
language translation, speech recognition, training of self-driving cars, and even stock market 
predictions.16 
Since its recent rise in popularity, deep machine learning has also made a significant impact 
on the medical field, specifically in the areas of diagnostic (radiology) and therapeutic (radiation 
oncology) radiological sciences.17 Applications in radiology and computer-aided diagnosis (CAD) 
have been at the forefront of application of machine and deep learning in medicine since the 
1980s.18-23 These applications included using artificial neural networks (ANNs) generally24 as well 
as convolutional neural networks (CNNs) for breast cancer detection and diagnosis.25-27 This 
pioneering work has led to several Food-and-Drug-Administration-approved systems including 
the QuantX Advanced system to aid in breast cancer diagnosis (CADx), developed originally by 
Giger and colleagues.28-32 Today, deep learning techniques are touching every aspect of 
radiology—from enhancing image quality by improving current image reconstruction and filtering 
of modalities such as MRI,33 CT,34 and ultrasound35; to image segmentation36 and registration37; 
and to precision medicine and the derivation of reproducible imaging biomarkers.38 
As another innovative and data-heavy field, radiation oncology is uniquely positioned to 
experience an explosion of deep learning applications. The number of radiation oncology and 
medical physics papers published which feature deep learning has increased steadily over the past 
five years, with a wide variety of applications including treatment planning,39-42 adaptive 
radiotherapy,35,43-46 quality assurance,47-50 and outcomes modeling.51-57 Figure 1.1 provides a 
visualization of the rise in deep learning both in biomedical literature and in publications specific 
to medical physics and radiation oncology.  
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Figure 1.1: Incidence of deep-learning-themed papers in biomedical literature as well as in medical physics 
and radiation oncology. Data was obtained through the advanced search function on PubMed. Search 
criteria used were (all fields: deep learning), (all fields: deep learning) AND (all fields: medical physics OR 
all fields: radiation oncology) and (all fields: deep learning) AND (all fields: radiology) respectively. 
 
1.3 Quantum-Inspired Algorithms and Quantum Computing 
Quantum mechanics was developed as a predictive framework to describe phenomena which 
violate the laws of classical physics. More specifically, quantum mechanics can be used to describe 
the behavior of systems in nature which exhibit parameters on the order of their de Broglie 
wavelength—such systems are referred to as “quantum systems.” 
In recent decades there have been efforts across multiple fields to harness quantum 
mechanics for application to problems outside of fundamental physics. Perhaps the most prominent 
example can be found in quantum computing, which seeks to develop algorithms designed to 
perform on specially built hardware in which quantum bits (qubits) perform computational 
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operations while in a quantum state. Quantum computers can leverage distinctly quantum 
processes such as superposition and entanglement to achieve superior performance over a classical 
computer for certain types of problems.58 
Quantum mechanics has also been used as a predictive framework to describe abstract 
processes which are not inherently “quantum” in nature. Quantum annealing (QA) was initially 
proposed by Kadowaki and Nishimori as an optimization method which models a quantum system 
under adiabatic conditions (i.e., no transfer of energy or mass between a process and its 
surroundings) to find the global minimum of an objective function; it has since been explored as 
an optimization method for radiation therapy treatment planning.59 There has also been success in 
utilizing quantum mechanics as a framework for modeling human cognition and decision 
making.60 It has been shown that quantum models are advantageous for modeling scenarios in 
which human decision-making violates the laws of classical probability, which have been found 
to occur under conditions of uncertainty or when sequential decisions are subject to order effects.61 
Based on these previous works, a motivation in the studies of this dissertation were, when 
appropriate, to investigate the use of quantum mechanics in conjunction with deep learning as a 
unified framework for addressing the challenges of ART. 
1.4 Motivation and Contributions of this Study 
This dissertation seeks to address some of the pressing challenges associated with wider 
implementation of adaptive radiotherapy—specifically the need for efficient and robust methods 
for treatment plan optimization, the need for robust frameworks for predicting patient anatomical 
variations, and finally the need to understand what kinds of patient characteristics can play a role 
in clinical outcomes. The following sections provide a brief description of the studies presented as 
well as their limitations and contributions. 
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1.4.1 Treatment Planning Optimization  
The first step in a radiotherapy process after consultation is the development of an appropriate 
treatment plan using virtual simulations to ensure its accurate delivery. This can be a laborious and 
time-consuming process, especially for ART applications where the plan may be updated/adapted 
several times during the course of the treatment. Hence, the focus of this study was to develop and 
investigate the use of a quantum-inspired algorithm, quantum tunnel annealing (QTA), for more 
efficient radiotherapy treatment plan optimization. We found that QTA converged up to 26.8% 
and 46.6% faster than the traditional simulated annealing when applied to direct aperture 
optimization and beamlet weight optimization, respectively. The results suggest that QTA could 
be an attractive optimization method in radiotherapy under scenarios that are currently hindered 
by lack of robust and efficient optimization. However, further studies will be necessary to better 
understand the performance of QTA under a wider variety of conditions, including different patient 
populations, additional structure sets, and objectives. 
1.4.2 Adaptation of Radiotherapy Plans to Geometrical Changes  
Patients undergoing radiotherapy may experience physiological and anatomical changes over the 
course of their treatment. Thus, the focus of this study was to develop and investigate two deep 
machine learning frameworks (one quantum-based and the other Markov-based) for predicting 
these anatomical changes during fractionated radiotherapy so that an optimal outcome can be 
achieved. This was evaluated in a population of head and neck cancer patients, which represent a 
population that typically experiences anatomical variations requiring plan adaption. The MRNN 
framework was found to have slightly better performance than the QRNN framework, with 
MRNN(QRNN)	validation AUC scores of 0.742 ±	0.021 (0.675	± 0.036), 0.709	± 0.026 (0.656 ± 
0.021), 0.724 ± 0.036 (0.652 ± 0.044), and 0.698 ± 0.016 (0.605 ± 0.035) for system state vector 
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sizes of 4, 6, 8, and 10, respectively. Of these, only the results from the two higher order states 
were found to have statistically significant differences (𝑝 < 0.05). A similar trend was also 
observed when the fully trained models were applied to an external testing dataset of 20 patients, 
yielding MRNN(QRNN) AUC scores of 0.707 (0.623), 0.687 (0.608), 0.723 (0.669), and 0.697 
(0.609) for states vectors sizes of 4, 6, 8, and 10, respectively. These results suggest that stochastic 
models have potential value in predicting patient changes during the course of adaptive 
radiotherapy. 
1.4.3 Radiotherapy Outcomes and Feature Identification 
It is recognized that different patients respond differently to radiotherapy. Thus, in the quest to 
develop personalized treatment plans, it is necessary to predict aforehand how an individual person 
would respond to radiotherapy. Hence, in this study we developed machine learning and deep 
learning models to identify patient clinical and imaging features which could be tied to relevant 
clinical outcomes in a larynx cancer population. Two features (gross tumor volume change 
between pre- and post-induction chemotherapy, and nodal stage) had prognostic value for 
predicting patient outcomes using standard regression models. The use of deep learning models 
was not found to improve model performance, but future studies incorporating more patient data 
could help to overcome model variance in this case. 
1.5 Dissertation Organization 
The remainder of this dissertation is organized as follows: Chapter 2 introduces relevant 
background on the topics and methodologies featured in this work, including fundamentals of 
radiation therapy, treatment planning, and adaptive radiotherapy; features relevant to models in 
radiation therapy; optimization methods; machine and deep learning models; and best practices for 
model evaluation. Chapter 3 presents a study on a quantum-inspired optimization algorithm for 
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radiotherapy treatment planning. Chapter 4 presents a study on a stochastic predictive framework 
for patient anatomical variations, and Chapter 5 presents a study on identifying relevant patient 
features predictive of outcomes in larynx cancer patients. Finally, Chapter 6 provides a general 
discussion of the contributions and limitations of the work presented in this dissertation. 
1.6 Accomplishments 
1.6.1 Awards 
• Medical Physics Distinguished Reviewer (2021) 
• Alternate for Rackham Predoctoral Fellowship (2020) 
• Medical Physics Editor’s Choice (2020): First author of article “Quantum-inspired 
algorithm for radiotherapy planning optimization” 
• Early Career Medical Physicist Scholarship Award (2019): Awarded at the 2019 Winter 
Institute of Medical Physics 
• University of Michigan Regents’ Fellowship (2016-2018)          
1.6.2 Peer-reviewed Publications 
• Pakela, J. M., Matuszak, M. M., Ten Haken, R. K., McShane, D. L., El Naqa, I. (expected 
early 2021) Dynamic Stochastic Deep Learning Approaches for Predicting Geometric 
Changes in Head and Neck Cancer. (submitted). 
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• Gharzai, L. A., Pakela, J. M., Jaworski, E., El-Naqa, I., Schonewolf, C. A., Hawkins, P. 
G., Wilkie, J. R., Spector, M. E., Bradford, C. R., Chinn, S. B., Hogikyan, N., Malloy, K., 
Kupfer, R., Shuman, A., Stucken, C. L., Prince, M., Shah, J., Swiecicki, P. L., Casper, K., 
Eisbruch, A., Wolf, G., Worden, F., Srinivasan, A., Mierzwa, M. L. (expected 2020/early 
2021) Imaging response versus operative laryngoscopy assessment of induction 
chemotherapy response in an induction bioselection approach to larynx cancer. 
(submitted). 
• Lee, S. Y., Pakela, J. M., Na, K., Shi, J., McKenna, B. J., Simeone, D. M., Yoon, E., 
Scheiman, J. M., Mycek, M-A. (2020), Needle-compatible miniaturized optoelectronic 
sensor for pancreatic cancer detection, Sci. Adv., 6(47): eabc1746. 
• Cui, S., Tseng, H.‐H., Pakela, J., Ten Haken, R. K. and El Naqa, I. (2020), Introduction to 
machine and deep learning for medical physicists. Med. Phys., 47: e127-e147.  
• Pakela J. M., Tseng H. H., Matuszak M. M., Ten Haken R. K., McShan D. L., El Naqa I. 
(2020), Quantum-inspired algorithm for radiotherapy planning optimization. Med. Phys., 
47(1): 5‐18.  
• Lee, S. Y.*, Pakela, J. M.*, Helton, M. C., Vishwanath, K., Chung, Y. G., Kolodziejski, 
N. J., Stapels, C. J., McAdams, D. R., Fernandez, D. E., Christian, J. F., O'Reilly, J., Farkas, 
D., Ward, B. B., Feinberg, S. E., Mycek, MA. (December 2017). Compact dual-mode 
diffuse optical system for blood perfusion monitoring in a porcine model of microvascular 
tissue flaps. J. Biomed. Opt., 22(12): 121609(1-14). 
* indicates co-first authorship 
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1.6.3 Book Chapters 
• Pakela J., El Naqa, I. (anticipated early 2021). Overview of Deep Machine Learning 
Methods. In I. El Naqa & M. J. Murphy (Eds.), Machine Learning in Radiation Oncology: 
Theory and Applications (2nd ed.). Springer International Publishing. 
• Niraula D., Jamaluddin J., Pakela J., (anticipated early 2021). Quantum Computing for 
Machine Learning. In I. El Naqa & M. J. Murphy (Eds.), Machine Learning in Radiation 
Oncology: Theory and Applications (2nd ed.). Springer International Publishing. 
1.6.4 Presentations 
• Pakela, J. M., Gharzai, L. A., Jaworski, E., Schonewolf, C. A., Hawkins, P. G., Bradford, 
C. R., Chinn, S. B., Hogikyan, N., Malloy, K., Kupfer, R., Spector, M. E., Shuman, A., 
Stucken, C. L., Prince, M. E., Shah, J. L., Srinivansan, A., Swiecicki, P. L., Casper, K., 
Worden, F., Wolf, G. T., Mierzwa, M. L., El Naqa, I. (October 2020). Roles of clinical and 
image-based features for outcomes in larynx cancer patients.  
Poster presentation at the American Society for Radiation Oncology (ASTRO) Annual 
Meeting, (virtual). 
• Pakela, J. M., Ten Haken, R. K., Mcshan, D. L., Matuszak, M. M., El Naqa, I. (July 2020). 
A quantum-inspired approach to predicting geometric changes in head and neck cancer.  
Blue ribbon poster presentation at the American Association for Physicists in Medicine 
(AAPM) Annual Meeting, (virtual). 
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• Jaworski, E., Gharzai, L. A., Pakela, J. M., El Naqa, I., Schonewolf, C. A., Hawkins, P. G., 
Bradford, C. R., Chinn, S. B., Hogikyan, N., Malloy, K., Kupfer, R., Spector, M. E., 
Shuman, A. Stucken, C. L., Prince, M. E., Srinivasan, A., Swiecicki, P. L., Casper, K., 
Worden, F., Mierzwa, M. L. (February 2020). Imaging response versus operative 
laryngoscopy assessment of induction chemotherapy response in an induction bioselection 
approach to larynx cancer. 
Oral presentation at the Multidisciplinary Head and Neck Symposium, Scottsdale, Arizona. 
• Pakela, J. M., Tseng, H. -H., Matuszak, M. M., Ten Haken, R. K., McShan, D. L., El Naqa, 
I. (June 2019). A quantum inspired algorithm for radiotherapy planning optimization.  
Oral presentation at the International Conference on the Use of Computers in Radiation 
Therapy (ICCR), Montreal, Canada.  
• Pakela, J. M., Tseng, H. -H., Matuszak, M. M., Ten Haken, R. K., McShan, D. L., El Naqa, 
I. (February 2019). Quantum-inspired algorithms for adaptive radiotherapy.  
Poster presentation at the Winter Institute of Medical Physics (WIMP), Breckenridge, CO. 
• Pakela, J. M., El Naqa, I., Matuszak, M. M., Ten Haken, R. K., McShan, D. L. (July 2018). 
Quantum Annealing for IMRT Optimization.  
Oral presentation at the American Association for Physicists in Medicine (AAPM) Annual 
Meeting, Nashville, TN. 
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• Pakela, J. M., Lee, S. Y., Hedrick, T. L., Vishwanath, K., Helton, M. C., Chung, Y. G., 
Kolodziejski, N. J., Staples, C. J., McAdams, D. R., Fernandez, D. E., Christian, J. F., 
O’Reilly, J., Farkas, D., Ward, B. B., Feinberg, S. E., Mycek, M.-A. (February 2017). In 
vivo preclinical verification of a multimodal diffuse reflectance and correlation 
spectroscopy system for sensing tissue perfusion. Oral presentation at SPIE Photonics 
West, San Francisco, CA. 
• Pakela, J. M., Hedrick, T. L., Lee, S. Y., Vishwanath, K., Zanfardino, S., Chung, Y. G., 
Helton, M. C., Kolodziejski, N. J., McAdams, D. R., Fernandez, D. E., Christian, J. F., 
Feinberg, S. E., Mycek, M.-A. (February 2017). Design verification of a compact system 
for detecting tissue perfusion using bimodal diffuse optical technologies.  
Poster presentation at SPIE Photonics West, San Francisco, CA. 
Underline indicates presenter 
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Chapter 2 Background 
 
This chapter contains excerpts from two book chapters and one review paper:  
1. Pakela J., El Naqa, I. (anticipated early 2021). Overview of Deep Machine Learning 
Methods. In I. El Naqa & M. J. Murphy (Eds.), Machine Learning in Radiation Oncology: 
Theory and Applications (2nd ed.). Springer International Publishing. 
2. Niraula D., Jamaluddin J., Pakela J., (anticipated early 2021). Quantum Computing for 
Machine Learning. In I. El Naqa & M. J. Murphy (Eds.), Machine Learning in Radiation 
Oncology: Theory and Applications (2nd ed.). Springer International Publishing. 
3. Cui, S., Tseng, H.‐H., Pakela, J., Ten Haken, R. K. and El Naqa, I. (2020), Introduction to 
machine and deep learning for medical physicists. Med. Phys., 47: e127-e147. 
2.1 Radiation Therapy 
Radiation therapy is a form of cancer treatment in which ionizing radiation is used to target and 
eradicate cancerous cells. Because ionizing radiation can also damage normal tissues, a major 
challenge of radiation therapy is to maximize the therapeutic window—i.e., maximize probability 
of local tumor control while minimizing the probability of normal tissue complications.1 Radiation 
therapy can be delivered in the form of implantable ionizing sources (brachytherapy) or through 
external beams of ionizing particles such as photons, electrons, or protons (external beam 
radiotherapy). An ideal treatment would involve delivering as much dose as possible to the tumor 
region with negligible dose to the surrounding normal tissue. Because it is not physically possible 
to perfectly localize radiation to only the tumor, in practice there is a tradeoff between delivering 
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as much dose as is necessary to eradicate the cancer while avoiding harmful dose levels to critical 
structures that could lead to side effects. 
Advancements in computing over the past several decades have helped to revolutionize 
radiotherapy (RT) treatment. In the late 1990s and early 2000s, the ability to efficiently perform 
optimizations on objective functions with hundreds or thousands of degrees of freedom allowed 
for the adaption of multileaf collimators (MLCs) into the treatment delivery process, leading to 
the rise of intensity modulated radiation therapy (IMRT) and volumetric arc therapy (VMAT). 
Both IMRT and VMAT achieve dose distributions which conform tightly around irregularly 
shaped/concave target structures, providing improved sparing of normal tissues and allowing the 
tumor to be safely treated with higher doses.2 These dosimetric improvements have resulted in 
IMRT methods becoming a regularly used standard of care.3 Advancements in computing have 
also allowed for the rise of image-guided radiotherapy—in which imaging is performed directly 
on the treatment couch right before or during therapy, allowing for improved alignment and motion 
management during treatment.4 
2.1.1 Types of External Beam Radiation Therapy 
As mentioned in the previous section, external beam radiotherapy (EBRT) involves targeting the 
tumor with beams of high energy photons, electrons, or protons. Due to their energy deposition 
properties, photons and protons are used for deep seated tumors, while electrons are reserved for 
superficial disease. EBRT is most commonly delivered in the form of photons due the prevalence 
of deep-seated tumors as well as the comparatively higher costs associated with proton therapy.5 
IMRT and VMAT represent two major modalities for photon delivery. Unlike 3-dimensional 
conformal radiation therapy (3DCRT), which utilizes multiple static beams, IMRT and VMAT 
beams are dynamically shaped during treatment using a device called a multi-leaf collimator 
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(MLC) which consists of movable pairs of radiation-blocking tungsten leaves. VMAT can be 
considered a type of IMRT in which the gantry also moves during treatment delivery across a pre-
determined arc.6 In addition to being capable of achieving highly conformal dose distributions 
associated with IMRT techniques, VMAT allows for each fraction of treatment to be delivered 
over a shorter time span.7  
2.1.2 Treatment Planning 
Treatment planning describes the process in the radiotherapy workflow during which a treatment 
plan is designed to meet the dosimetric constraints prescribed by the radiation oncologist. 
Typically, the dosimetric constraints consist of lower dose limits for diseased tissue and upper 
dose limits for normal tissues and critical structures. There are three categories of volumes which 
receive lower dose limits in radiotherapy. The gross tumor volume (GTV) is defined as the region 
in which the tumor can be physically observed via imaging. In order to account for uncertainties 
regarding the presence of microscopic disease spreading from the edges of the viewable tumor, a 
margin is drawn around the GTV, and the volume contained within this margin is referred to as 
the clinical target volume (CTV). Finally, to account for random motion uncertainties associated 
with daily setup and anatomical variations, an additional margin is drawn around the CTV; the 
volume within is referred to as the planning target volume (PTV).8  
For EBRT, treatment planning requires the selection or optimization of several different 
types of parameters including the number of beams to use, the orientation of those beams (in the 
case of VMAT, the arc path through which the beam traverses), as well as fluence vectors or 
aperture shapes (which determine how much radiation the MLC allows to flow through each beam 
aperture and where). While certain parameters (such as number of beams, beam orientations, or 
arc paths) can either be optimized or selected by an experienced treatment planner, others (such as 
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fluence vectors/aperture shapes) represent thousands of degrees of freedom and thus require the 
use of computational optimization algorithms. The time and resource constraints associated with 
a busy clinical environment as well as the growing interest in incorporating complex, biologically 
driven objectives result in a need for robust, efficient optimization algorithms. 
2.1.3 Adaptive Radiotherapy for Head and Neck Cancer 
The concept of adaptive radiotherapy (ART) was first proposed in the literature by Yan et al. in 
1997 as a means of delivering personalized treatment and safely performing dose escalation 
through the modification of radiotherapy plans mid-treatment in response to measured changes in 
the patient.9 ART methods are categorized by the timeframe over which the adaption is made. In 
online ART, plan adaptions are made immediately before a treatment while the patient is 
immobilized on the treatment couch and are performed over a timescale of minutes. In offline 
ART, plan adaptions are made between treatment fractions and can occur over a timescale ranging 
from hours to days. Because CBCT imaging has become a ubiquitous standard of care to ensure 
proper daily alignment with the treatment plan, it is common practice to utilize CBCT images to 
perform geometric adaptions, in which adaptions are made based on measured changes to the 
patient’s geometry.10 There has also been interest in utilizing functional imaging such as Positron 
Emission Tomography (PET) or diffusion-weighted magnetic resonance imaging (MRI) to 
perform biological adaptions, in which biomarkers guide ART.11 
Figure 2.1 provides a visualization of the radiotherapy workflow. The teal boxes represent 
the standard (i.e., non-adaptive) RT workflow while the white boxes represent an adaptive 
workflow, highlighting the primary questions and uncertainties which still need to be addressed 
for clinical implementation, including: “What types of information should be used for determining 
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the need for adaptation?”, “What should be the necessary criteria to trigger a plan adaption?”, and 
“What kind of adaption should occur, when, and how often?”. 
 
Figure 2.1: Visualization of radiotherapy workflow highlighting some of the primary questions and 
uncertainties surrounding the implementation of ART techniques. 
 
Given that the clinical implementation of ART represents a complex, multifaceted problem, 
it has been the subject of many different areas in research. One broad area of research is the 
identification of patient populations who are most likely to benefit from ART procedures.12,13 
Another critical area of ART research is to develop technology which allows ART to be 
implemented within time and resource constraints of a clinical setting. This technology can take 
the form of algorithms for improving daily pre-treatment image quality,14-16 improved image 
registration techniques for accurate mapping of structures,17-19 algorithms for faster treatment plan 
optimization and dose estimation,20-22 and outcome prediction as well as optimal treatment 
decision models to aid in clinical decision making.23-29 
 23 
2.2 Handcrafted Features 
In machine learning, a feature refers to a quantitative, measurable property which serves as an 
input to a model.30 Handcrafted features are variables which are selected manually using expert 
knowledge. Commonly used handcrafted features in radiotherapy modeling include clinical and 
anatomical patient features, including demographics such as age and gender, genetic information 
(genomics), disease-specific features such as tumor site and disease stage, treatment-specific 
features such as dose prescription, and quantitative radiological imaging features (radiomics) 
which are discussed in further detail below. 
2.2.1 Radiomic Features 
Radiomic features are quantitative variables extracted from medical-image data (typically 
radiology images such as computed tomography [CT], positron emission tomography [PET], or 
magnetic resonance imaging [MRI]).31 Radiomic features include morphological features such as 
volume or surface area as well as texture features which are calculated using the intensity levels 
within a region of interest (ROI) (such as the 3D CT contour of the GTV) of an isotropic image. 
Texture features can be further classified into global (first order) features and local (higher order) 
features. Global texture features can be calculated directly from the normalized intensity 
distribution histogram 𝑝 and the average gray-level. Given an isotropic volume contained within 
an ROI, and P(i) representing the number of voxels with gray level, i, the ith entry of the 
normalized intensity distribution histogram can be defined as:  




Where 𝑁! is the number of gray level bins.32 
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Higher order texture features include Gray-Level Co-occurrence Matrix (GLCM) features, 
Gray-Level Run-Length Matrix (GLRLM) features, Gray-Level Size Zone Matrix (GLSZM) 
features, and Neighborhood Gray-Tone Difference Matrix (NGTDM) features. Higher order 
texture features differ from global texture features in that each of the matrices used to calculate 
these features include a distance parameter in the computation, allowing them to capture spatial 
patterns and interrelationships between voxels.31 Image processing and feature extraction for 
radiomic features in Chapter 5 were performed using the Radiomics toolbox in MATLAB.33 
2.3 Optimization Algorithms 
Optimization problems can be formulated as the goal of finding the minimum value of an objective 
function E(𝑥) with respect to a set of optimization parameters, 𝒘: 
 	min𝒘 𝐸(𝒘)	 2.2 
In radiotherapy treatment planning, the optimization parameters, 𝒘, can represent a number of 
different variables, such as fluence weights over the beam’s cross sections, MLC aperture shapes, 
or beam orientations. One challenge in radiotherapy treatment planning optimization is that the 
objective function often contains terms such as dose volume penalties which render it non-convex, 
making optimization more difficult because the solution space may contain many local minima 
and is not guaranteed to have a single global minimum. 
2.3.1 Gradient Descent 
Gradient descent is an iterative optimization method which searches for the local minimum of an 
objective function by updating the solution via the gradient of the objective function with respect 
to the optimization parameters: 
 𝒘('($) = 𝒘(') − 𝜂∇E(𝒘('))	 2.3 
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Where 𝜂 serves as the learning rate coefficient and is usually chosen as a small number. One 
limitation of gradient descent is that the solution can become trapped in local minima for non-
convex optimization functions.34 
2.3.2 Simulated Annealing 
Simulated annealing (SA) is an iterative, stochastic optimization algorithm which approximates a 
global minimum of a function.35 After initializing the optimization parameters as a first guess, a 
new potential solution, 𝑤′, is randomly selected from the neighborhood of the current solution 
space. If the potential solution yields a lower objective function score than the current solution 
(𝐸(𝑤′) < 𝐸(𝑤)),), the new solution is accepted and set as the current solution. If the potential 
solution is found to be worse than the current solution (𝐸(𝑤′) > 𝐸(𝑤)), the potential solution is 
accepted as the current solution with probability 𝑃 = exp 8"∆$
%
9, where 𝑇 is an annealing 
parameter that represents the “temperature” of the system and is gradually decreased so that it 
approaches 0 by the end of the algorithm. By allowing the algorithm to occasionally accept worse 
solutions, SA is able to avoid becoming trapped in local minima. It has been shown theoretically 
that if 𝑇 is decreased slowly enough, SA is guaranteed to find the global minimum of E.  
2.4 Classical Machine Learning Algorithms 
Classical machine learning refers to any machine learning algorithm which use handcrafted 
features (also called feature vectors) to identify patterns in data. This section provides a brief 
overview of classical machine learning methods utilized in this work. 
2.4.1 Logistic Regression 
Logistic regression (LR) is a binary classification model which can be used for outcome prediction, 
disease classification, and as a way to estimate the relative importance between various patient 
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features and clinical outcomes. LR assumes the natural log of the odds ratio (also called the logit) 




7 	 = 	𝜷 ∙ 𝒙 2.4 
Where 𝜋 represents the probability of outcome 𝑌 = 1, 1 − 𝜋 represents the probability of the 
alternative outcome 𝑌 = 0, and 𝜷 represents regression coefficients learned during model training 
(typically using the maximum likelihood estimation).36 The posterior probability of a sample with 
feature vector 𝒙 can thus be written as: 
 𝑃(𝑌 = 1|𝒙) = 	𝜎(𝜷 ∙ 𝒙) 2.5 
Where 𝜎(𝑎) is the logistic sigmoid function: 




2.4.2 Cox Proportional Hazards Model 
For certain kinds of medical data, it is also relevant to consider the “time to event” associated with 
binary outcomes. For a set of patients each characterized by a feature vector (or covariates), 𝒙, the 
Cox proportional hazards (Cox) model assumes the risk of an event occurring for a given patient 
at time, t, to take the form of the hazard function: 
 ℎ(𝑡) = 	ℎ*(𝑡) ∗ exp	(𝜷 ∙ 𝒙) 2.7 
Where ℎ&(𝑡) is the baseline hazard, and the set of covariate coefficients, 𝜷, are fit during model 
training and represent the relative importance of each feature in 𝒙.37 The values exp(𝛽') are 
referred to as hazard ratios and describe how each covariate contributes to the risk of event, with 
exp(𝛽') greater than (less than) 1 indicating that the risk to the patient increases (decreases) as 𝑥' 
increases. 
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2.5 Deep Learning  
Deep machine learning or “deep learning” refers to a class of machine learning methods which 
take raw data as inputs and, through training, learn multiple layers of relevant latent features to 
map the raw inputs to the desired output space; the desired mapping is defined by either a reward 
or a loss function of the outputs for detection or classification tasks.38 This is in contrast to 
shallow/classical machine learning, where the features are manually crafted and do not contain 
multiple layers of abstraction. Conceptually then, deep learning can be applied to any machine 
learning technology as depicted in Figure 2.2, but as of this time it has been practically shown to 
be most effective with deep neural networks.39,40 
 
Figure 2.2: Conventional “shallow” machine learning (top) versus deep learning algorithms, where image 
data representation and classification are handled within the same framework. 
 
Deep learning algorithms typically take the form of artificial neural networks (ANNs) with 
multiple hidden layers; however, it is important to recognize that deep learning is defined by the 
ability to automatically learn relevant features (data representations) from raw inputs rather than 
any particular structure scheme.40 
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2.5.1 Fully Connected Neural Networks 
A standard “fully connected” or “vanilla” neural network is one of the primary building blocks of 
many neural network models. A fully connected neural network consists of layers of neurons (also 
called “units” or “nodes”). In a given layer, each node has weighted connections to every node in 
the previous layer and every node in the next layer. Nodes do not share connections within the 
same layer. This forward-directed flow of information is why vanilla neural networks are also 
referred to as “feedforward neural networks.” In literature, one may also see the term “multilayer 
perceptron” used to refer to fully connected feedforward neural networks.  
The structure of a three-layer vanilla neural network is visualized in Figure 2.3. The first 
layer in the neural network is the input layer, 𝐱()). The input layer takes raw data inputs and 
propagates them to the next layer. The final layer, 𝐱(+), is the output layer. The results from the 
output layer represent the network’s output and are used to define a loss function. The width (i.e., 
number of nodes) for the input and output layers are typically determined by inherent 
characteristics of the data and the task the network performs. For example, a network designed to 
use grayscale images with 28 × 28 pixels will have 784 nodes in its input layer, where each node 
represents the intensity of a pixel in the image. If the task for the network is to classify handwritten 
digits, then the output layer will have a width of 10, with each node outputting the raw prediction 
score (to be later normalized into a probability) of a given digit. Hidden layers (𝐱(,)) consist of all 
layers between the input and output. The width and total number of hidden layers are 
hyperparameters, meaning their values are chosen by the user and are not updated during training. 
The act of selecting/tuning hyperparameters for a given model is an active area of research and 
considered an art in and of itself.41,42 
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Figure 2.3: A three-layer neural network (input layer, hidden layer, and output layer). The output of each 
node is determined by performing a non-linear transformation (known as the activation function) on the 
sum of the weighted inputs plus an additional bias term. 
 
2.5.2 Training a Neural Network 
The process of training a neural network involves training a set of weights and biases which act 
like “knobs” to control the flow of information across the network. The number of weights and 
biases needed to train depends on the size of the network: the example neural network shown in 
Figure 2.3 has 128 weights and 12 biases, but a typical network can have hundreds of millions of 
weights.40 As mentioned in Section 2.5.1, each node in a neural network receives information from 
each of the nodes in the previous layer (this can be visualized through the color-coded arrows in 
Figure 2.3). The output for each node is a function of the weighted sum of each incoming signal 
plus a bias term. We can therefore write the output for a given node, 𝑥-
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Where 𝑊'- represents the weight associated with the connection from node 𝑥'
(.)to 𝑥-
(./)), 𝑏- is the 
bias associated with node 𝑥-
(./)), and 𝜎 is the activation function. In a biological neural network, 
in order for a neuron to fire, it needs to receive enough electrical signal from other neurons to 
overcome a threshold known as the activation potential. In artificial neural networks, the activation 
function performs a similar role to the activation potential: it determines whether the node has 
received enough “signal” to fire. Common choices for activation functions include the hyperbolic 
tangent, sigmoid, softmax, and Rectified Linear Unit (ReLU) functions. Of these three, ReLU is 
arguably the most popular as it has been found to make networks more easily trainable.40,43 Figure 
2.4 displays equations and graphical representations for each of these functions. Importantly, one 
trait that all neural network activation functions share is that they are non-linear functions: they 
perform a nonlinear operation or transformation on input features to produce an output. This trait 
is significant because it allows neural networks to model complex, non-linear relationships 





Figure 2.4: Common nonlinear activation functions used in neural networks. 
 
At the start of training, the weights and biases of the network are initialized. A common 
method for initialization which has been found to work well is the Xavier initialization, in which 
the biases are initially set to 0 and the weights for a given node are randomly sampled from a 








Where 𝑛- and 𝑛-/) are the number input and output connections to the node, respectively.44 
Another popular initialization technique is He initialization,45 which instead bounds uniformly 















Tanh: 𝑦 = 	 tanh(𝑥) 




After initialization, data is fed into the network, which produces an output. This output is then fed 
into a cost function (also called a loss function) to calculate a loss. The weights and the values of 
the network are then updated via gradient descent. The gradient of the loss function is calculated 
with respect to the weights and biases of every node in the network using the chain rule. Each of 
these parameters is then updated by adding the gradient term multiplied by a fractional learning 
rate typically on the order of hundredths or thousandths. This process is then repeated in an 
iterative fashion until a stopping criterion is met—either the loss reaches a minimum criterion, or 
a max number of iterations is performed. For a large network, calculating the gradient of the loss 
function with respect to millions of parameters is a computationally expensive endeavor. A major 
breakthrough in the deep learning community was the introduction of the backpropagation 
algorithm, which provided an efficient means of calculating the loss gradient with respect to 
network parameters.38,46 
2.5.3 Hyperparameters Associated with Training 
Four significant hyperparameters associated with the training process are batch size, number of 
epochs, learning rate, and dropout rate. The batch size is the number of data samples fed to the 
network before the weights and biases are updated. Batch size can range from 1 (the network is 
updated after a single sample) to the size of the training dataset (the network is only updated after 
it has seen every possible data sample). Training schemes with a batch size of 1 are referred to as 
stochastic gradient descent, while training schemes with a batch size equal to the number of 
training samples are referred to as just gradient descent or batch gradient descent. If the batch size 
is a number between 1 and the training sample size, the algorithm is said to undergo minibatch 
gradient descent. Of these three training schemes, batch gradient descent is the least noisy because 
it uses every data sample when calculating the gradient—meaning it isn’t going to be impacted by 
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variations within the dataset. However, for very large datasets (on the order of millions of training 
examples) it is computationally expensive to pass all of the data through the network before each 
update, which increases the overall training time. Stochastic gradient descent leads to a much 
noisier learning process because the network is updated after only a single data sample, which may 
not be representative of the dataset as a whole. A benefit of stochastic gradient descent is that in 
updating after only a single sample, the loss function may approach a value close to the global 
minimum at a faster rate. However, this also means the network must be updated more frequently, 
which is also computationally expensive. Minibatch gradient descent serves as a compromise 
between these two extremes by using a batch size large enough to be somewhat representative of 
the entire dataset, which minimizes training noise, but small enough that the network is able to 
update more frequently, leading to faster overall training times. During training, it is standard to 
normalize the network inputs on a batch by batch basis—a procedure called batch normalization—
in order to improve the training speed and model stability.47 
An epoch refers to an instance in which the entire training dataset has been passed through 
the network. The number of epochs is thus a hyperparameter which describes how many times the 
entire dataset is passed through the network during training. Typically, a network requires the 
entire training dataset to be passed through multiple times before the loss function converges to a 
minimum.  
The learning rate is a fractional coefficient applied to the loss function gradient and can be 
thought of as the step size used when updating the weights and biases to minimize the loss function. 
A popular choice for neural network optimization is to use an adaptive learning rate defined using 
the Adam stochastic optimization algorithm.48 
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Dropout is a standard practice used during neural network training to prevent overfitting 
of the model. It consists of randomly selecting a set number of nodes in the network and setting 
their output to 0, effectively dropping them (and their connections) from the network. The fraction 
of neurons in a given layer which are dropped during training is called the dropout rate.49 
2.5.4 What Makes a Neural Network Deep? 
Deep machine learning was defined in 2.5 as any machine learning method which learns multiple 
layers of latent features from raw data. Deep neural networks are by far the most successful deep 
learning architecture to date—so much so that the phrase deep learning is sometimes used 
interchangeably with neural networks. This subsection aims to provide some intuition as to why 
and under what conditions neural networks perform so well.  
One important property of neural networks (already mentioned in 2.5.2) is the use of 
nonlinear activation functions, which allow the model to learn nonlinear relationships between 
data and outputs. With respect to modeling capabilities, it has been proven that neural networks 
are universal approximators: a feedforward neural network with as few as one hidden layer and 
arbitrary bounded, non-constant activation functions can be used to approximate any real, 
continuous function on a closed and bounded subset of ℝ3 to any accuracy.50 This result is often 
referred to as the universal approximation theorem and tells us that a multilayer feedforward neural 
network can represent nearly any function given a sufficient number of hidden nodes. The result 
has undergone multiple iterations to clarify what conditions the activation function must meet for 
the theorem to be true—notably showing that the universal approximation theorem extends to the 
highly successful ReLU activation function.51,52 
A key limitation of the universal approximation theorem is that it does not tell us how large 
(in terms of layers or neurons) the network needs to be in order to achieve universal approximation, 
 35 
nor does it guarantee that a sufficiently large network can be successfully and efficiently trained 
to be generalizable—i.e., a network that is large enough to represent any function may be trained 
to perform with high accuracy on the training dataset but still perform poorly on the validation 
data.52 While a shallow neural network with only one hidden layer is capable of being a universal 
approximator, such a network requires so many nodes in its hidden layer that efficient and effective 
training is infeasible: it is too wide.52,53 It has been found that neural networks with more hidden 
layers reduce the necessary width for each layer and ultimately the total number of nodes needed 
for high accuracy, providing the best tradeoff between training efficiency and model performance. 
Generally, a neural network is considered deep if it has multiple hidden layers. 
2.6 Model Evaluation and Benchmarking 
This section describes both performance metrics for evaluating data-driven models as well as 
frameworks for applying these metrics. A main goal of evaluating data-driven models is the 
assessment of their generalizability, i.e., after the model has learned a functional mapping from 
given inputs to outputs using training data, how well does that model then perform in the real world 
on unseen data? In order to assess generalizability, it is standard practice to reserve a portion of 
the available data from training to use for evaluation of the model.  
2.6.1 Performance Evaluation: Area Under the Receiver Operating Characteristic Curve and 
Harrel’s C-Index 
Two standard measures of model performance are the area under the receiver operating 
characteristic curve (AUC) and Harrel’s c-statistic or c-index. For binary classification models, 
the model output consists of a score representing the probability of being in class 1 (subtracting 
the score from 1 produces the probability of being in class 0). A threshold value, t, is selected such 
that any output whose score is greater than or equal to the t is assigned to class 1; otherwise, it is 
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assigned to class 0. The resulting classification predictions can be used in conjunction with the 
ground truth labels to calculate the model sensitivity or true positive rate (TPR), which is defined 
as the ratio of the number of correctly classified samples from class 1 to the total number of 
samples from class 1, and the false positive rate (FPR), which is defined as the ratio of samples 
incorrectly classified as belonging to class 0 to the total number of samples in class 0. The receiver 
operating characteristic (ROC) curve is defined as the curve obtained from plotting the TPR 
against the FPR for all possible values of the threshold, t, ranging from 0 to 1. The AUC is defined 
as the area under this curve and ranges in value from 1 (indicating a perfect classifier) to 0 
(indicating the classifier is wrong 100% of the time). An AUC score of 0.5 indicates the model 
performs no better than random guessing. The AUC is a valuable performance metric because it 
is independent of the choice of classification threshold and can also be generalized to multi-class 
models.54 
The c-index provides a global assessment of performance for survival models. It is defined 
as the probability that for two randomly sampled patients, the patient with the higher survival score 
will outlive the patient with the lower survival score54; this can be considered a generalization of 
the AUC.55 Similar to the AUC, a c-index value of 1 indicates that the model correctly assigns risk 
to each possible pair of patients 100% of the time, while a c-index value of 0.5 indicates the model 
performs no better than random guessing. 
2.6.2 Cross Validation 
Cross validation is a specific procedure for model evaluation which helps to minimize selection 
bias—i.e., bias introduced by the choice of how the data is split between the training and 
validation. The premise of cross validation is to randomly split the available dataset into 𝑘 equally 
sized subsets referred to as “folds.” The model is then trained using the first 𝑘 − 1 folds and 
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evaluated on the remaining “hold-out” fold. This process is then repeated 𝑘 − 1 times, until every 
combination of training and hold-out folds has been exhausted. The model’s final validation score 
is then calculated as the average of the 𝑘 validation scores using a chosen performance measure. 
When 𝑘 is equal to the total number of data samples, each hold-out set contains only one sample, 
and the procedure is referred to as leave one out cross validation (LOOCV). For smaller values of 
𝑘, the procedure is called k-fold cross validation. Cross validation is particularly useful when the 
available dataset is small, as smaller datasets are more vulnerable to selection bias. 
Another variant of cross validation utilized in this work is nested cross validation. In k-n-
nested cross validation, the model undergoes two loops of cross validation. The outer-loop splits 
the original dataset into 𝑘 folds, where training partitions are made up of 𝑘 − 1 folds, with the 
remaining fold reserved for validation. During each iteration of the outer loop, prior to training 
each training partition is further split into 𝑛 folds, which then undergo n-fold cross validation. This 
n-fold cross validation is referred to as the inner loop. Nested cross validation is a valuable tool 
for hyperparameter tuning and feature selection in a cross validation paradigm because it allows 
for model selection to occur independently for each outer validation, reducing selection bias.56 
2.7 Quantum Algorithms and Quantum Computing 
2.7.1 Overview of Quantum Computing 
Quantum computing refers to the use of quantum mechanical systems to perform computational 
tasks. The original inspiration for the concept of quantum computing is credited to physicist and 
Nobel prize laureate Richard Feynman, who postulated in the 1970s that a quantum computer 
could solve problems that classical computers cannot. This idea followed a proposal by Paul 
Benioff of a quantum mechanical model of the Turing machine.57  
 38 
In classical computing, the basic unit of information is a called a bit, which can take the 
value of either 0 or 1. In quantum computing, the quantum counterpart of a bit is called a qubit; 
unlike classical bits, qubits can exist simultaneously in both states at once (also called a mixed 
state), which can be represented by a linear superposition: 
 |Ψ⟩ = 	 𝑐$|0⟩ + 𝑐-|1⟩ 2.11 
Where the probability amplitudes 𝑐) and 𝑐, are complex numbers. Only upon an event (i.e., a 
quantum measurement) will the qubit |Ψ⟩ collapse to a binary quantum state (either |0⟩ or |1⟩ with 
probability |𝑐)|, or |𝑐,|,, respectively). By extension, a quantum system containing 𝑛 qubits 
(called an n-qubit register) can represent 23 states simultaneously. For instance, a 2-qubit system 
defined as a uniform superposition state, |Ψ⟩ = )
,
(|00⟩ + |01⟩) + )
,
(|10⟩ + |11⟩) represents 4 
states simultaneously. This property of being able to exist simultaneously in multiple states at once 
is known as quantum superposition, which further allows for quantum parallelism—providing 
quantum computing with a much faster computational speed than its classical counterpart. 
Quantum parallelism is the ability to simultaneously operate on all the superimposed states 
in parallel. Since the number of states represented by a qubit register grows exponentially with the 
number of registers, an operation performed on a quantum computer would have taken an 
exponential number of operations on a classical computer with the same numbers of registers. One 
tradeoff of quantum parallelism is that the probability of measuring one particular state out of 23 
states also decreases exponentially.  
Another quantum mechanical phenomenon relevant to quantum computing is quantum 
entanglement. Quantum entanglement refers to a phenomenon in which 2 or more qubits in a multi-
qubit system are correlated with each other. For example, in a maximally entangled 2-qubit state 
(also called a Bell state) given by: |Ψ⟩ = )
√,
(|00⟩ + |11⟩), |Ψ⟩ can be found upon measurement 
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to be in either state |00⟩ or state |11⟩, each with a probability of 50%. What this means is that if 
the first qubit is measured to be in the |1⟩ state, the second qubit will also collapse to the |1⟩ state; 
the outcome of the second qubit is intrinsically tied to the first, and vise-versa. The entanglement 
phenomenon provides quantum computing with a resource absent in classical computing that 
makes classically impossible processes, like super-dense coding and quantum teleportation, 
possible. An actively sought out real-life application of quantum communication is to create an 
eavesdrop-proof channel for key distribution in cryptography.58 For practical purposes, this 
translates to an efficient representation of highly correlated information, which is still a challenge 
in classical computation. 
A quantum algorithm refers to a set of instructions for performing a calculation via 
operations on qubits. While it is possible for quantum algorithms to be simulated on a classical 
computer, often any theoretically hoped-for computational advantage can only be realized using a 
quantum computer—a hardware device which allows calculations to be performed on physical 
(rather than simulated) quantum states. Along with quantum information theory, quantum 
hardware is an area of active research with growing interest from both the private sector and the 
government.59-61 A quantum computer is built from quantum circuits and quantum gates, just like 
classical computers are made up of electrical circuits and logic gates. The physical realization of 
quantum circuits has been achieved through different means: trapped ions,62 nuclear magnetic 
resonance (NMR), linear optical systems, and superconducting solid-state system.63 Currently, 
superconducting solid-state systems are the main focus in commercial sectors and companies—
with Google, IBM, Microsoft, and Intel racing to build a universal quantum computer—whereas 
nuclear magnetic resonance (NMR), optical, and trap ion computing systems are most actively 
researched in academic and governmental institutes. 
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2.7.2 Postulates of Quantum Mechanics 
Quantum mechanics is a mathematical framework which was invented as a means of describing 
and understanding physical systems in nature which were observed to disobey the laws of classical 
physics. Quantum mechanics can be summarized as a set of postulates (or logical assumptions), 
which are presented briefly in this section. 
1. The state of a quantum mechanical system is completely represented by a normalized ket, 
|𝜓⟩.  
Mathematically, kets are vectors that reside in an inner-product vector space over complex number 
field called Hilbert Space. While Hilbert Space can represent infinite dimensional space, the 
dimensionality of the Hilbert space is determined by the physics of a problem. Vector spaces 
satisfy the closure property, i.e., the linear combination of any two vectors of a vector space must 
lie in the same vector space. This implies that the superposition of two states is also a state of the 
system: if |𝜓&⟩ and |𝜓)⟩	are two possible states of a system, then so is |𝜓⟩ = 𝑐&|𝜓&⟩ + 𝑐)|𝜓)⟩, 
where 𝑐& and 𝑐) are complex numbers. In Dirac notation, a `bra' (⟨		|) is the dual of a vector `ket' 
(|		⟩) and together in the bra-ket succession define an inner product. Mathematically, `bra' denotes 
a linear functional 𝑓:	𝑉 → ℂ that maps vector 'ket' to a number in the complex plane. The Dirac 
notation simplifies the inner product notation especially for states of continuous variables, which 
are represented in terms of wave functions, i.e.,  
 ⟨Ψ|𝜙⟩ = [𝑑𝑥Ψ∗(𝑥)𝜙(𝑥) 2.12 
2. Every physical observable attribute of a quantum mechanical system is described by 
Hermitian operator, 𝑂b, that acts on kets describing that system. 
Observables are physically measurable attributes such as position, linear and angular momentum, 
energy, and so on. An operator is Hermitian if it is equal to its conjugate transpose, i.e., 𝑂 = 𝑂5. 
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This property guarantees real eigenvalues necessary for the observables to be physical. An operator 
𝑂b acting on a ket |𝜓⟩ is denoted by left multiplication i.e., |𝜓6⟩ = 𝑂b|𝜓⟩. In general, the operation 
changes the state of the quantum system. 
3. The only possible result of a measurement of an observable 𝑂 is one of the eigenvalues of 
the corresponding operator 𝑂b .  
This postulate describes the source of the word "quantum." If the observable is of continuous 
spectrum, like position or momentum, then the measurement will give us classical results. 
However, if the observable has a discrete spectrum, like the angular momentum of an orbiting 
electron, the measurement will yield discrete set of values in multiples of Planck's constant. 
4. Upon a measurement of the observable	𝑂 on a quantum mechanical system in the state |𝜓⟩, 
the probability of obtaining the eigenvalue 𝑂 is given by the square of the inner product of 
|𝜓⟩ with the eigenstate |𝑜3⟩, i.e., |⟨𝑜3|𝜓⟩|,. 
Besides having real eigenvalues, the eigenstates of a Hermitian operator are orthogonal, i.e., 
d𝑜'e𝑜-f = 𝛿'- where the Kronecker delta 𝛿'- = 1 for 𝑖 = 𝑗 and 𝛿'- = 0 otherwise. The orthogonal 
eigenstate spans the space of states and forms a basis. This means that the state of a quantum 
mechanical system can be expanded as a linear combination of the eigenstates of a Hermitian 
operator with complex coefficients. 
 |𝜓⟩ = 	G𝑐/|𝑜/⟩
/
 2.13 
The complex coefficients, ⟨𝑜3|𝜓⟩ = 𝑐3, represent the probability amplitude associated with the 
eigenstate |𝑜3⟩. This means that |𝜓⟩ = ∑ ⟨𝑜3|𝜓⟩3 |𝑜3⟩ and hence ⟨𝜓|𝜓⟩ = ∑ |⟨𝑜3|𝜓⟩|,3 . Since 
⟨𝜓|𝜓⟩ is the total probability and sums to 1, |⟨𝑜3|𝜓⟩|, is the individual probability associated with 
measuring eigenstate 𝑜3. The probabilistic interpretation requires the normalization of kets, i.e., 
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⟨𝜓|𝜓⟩ = 1, which can be achieved by dividing |𝜓6⟩ by its norm, k⟨𝜓6|𝜓6⟩, where prime notation 
represents the state before normalization. 
5. Immediately after the measurement of the observable 𝑂 that yielded the value 𝑜3, the state 
of the system collapses to the normalized eigenstate |𝑜3⟩. 
This postulate is "counterintuitive" with respect to quantum mechanics. Measurements of 
observable 𝑂 after preparing several identical quantum mechanical systems in state |𝜓⟩ can yield 
different results. This is to be expected, as quantum mechanical states are probabilistic in nature 
and can exist in a superimposed state. However, carrying out a second measurement immediately 
on a system that yielded 𝑜3 value in the first measurement will always yield 𝑜3.  
6. The time evolution of a quantum mechanical system preserves the normalization of the 
associated ket. The time evolution of the state is a unitary transformation described by 
|𝜓(𝑡)⟩ = 	𝑈m(𝑡, 𝑡&)|𝜓(𝑡&)⟩. 
The preservation of normalization during time evolution of a quantum mechanical system implies 
conservation of probability: the probability of finding a system in an eigenstate summed over all 
possible eigenstates must be 1. This is ensured by setting the time evolution operator as a unitary 
transformation. Mathematically, unitary transformations preserve inner products: the inner product 
of kets are equal to the inner products of the transformed kets, i.e., ⟨𝜓|𝜓⟩ = d𝜓e𝑈5𝑈e𝜓f which is 
true when 𝑈5𝑈 = 1, implying 𝑈5=𝑈"). By symmetry of the inner product operations, 𝑈5𝑈 = 𝐼 =
𝑈𝑈5. Practically, unitary transformations are reversible operations such as rotation and reflection, 
i.e., an inverse transformation of equal magnitude will nullify the forward transformation and send 
a state back to its original state.  
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2.7.3 Quantum Cognition and Decision Theory 
Although quantum mechanics was originally invented as a predictive framework to describe the 
behavior of physical systems in nature, in recent decades it has also been adapted by the field of 
psychology as a framework for modeling human behavior and decision making.64 The motivation 
for applying a quantum framework to model human cognition/decision making comes from the 
observation of scenarios in which human behavior violates classically based Kolmogorov 
probability theory. One important example is the violation of the “sure-thing” principle, which 
states that if a person prefers action A over action B under the state of world X, and also prefers 
action A over action B under the complimentary state of world X’, then the person should prefer 
action A over action B even if they do not know the state of the world.65 Researchers have 
experimentally shown that humans often violate the “sure-thing” principal when asked to make 
decisions under conditions of uncertainty,66,67 leading to a violation of the law of total probability, 
which states: 
 𝑃(𝐴) = 𝑃(𝐴|𝑋) ∗ 𝑃(𝑋) + 𝑃(𝐴|𝑋0) ∗ 𝑃(𝑋0) 2.14 
The benefit of adopting a quantum framework for probabilistic modeling of human behavior is 
that because quantum theory is not bound by the law of total probability, it can more accurately 
predict human behavior under certain conditions—namely scenarios in which certain aspects of a 
system are uncertain to the decision-maker or subject to order-effects.68 These studies help to 
provide insight into how quantum mechanics may be utilized for modeling other abstract systems 
under conditions of uncertainty.  
2.7.4 Quantum Annealers 
Quantum annealers refer to a class of quantum hardware which solve optimization problems 
through the process of quantum annealing (QA). First proposed by Kadowaki and Nishimori,69 
 44 
QA exploits the result of the quantum adiabatic theorem which states that when a quantum system 
undergoes a gradual change in its total energy from 𝐻' to 𝐻7, if it starts out in the 𝑛89 eigenstate 
of 𝐻' then it will end up in the corresponding 𝑛89 eigenstate of 𝐻7. This means that a quantum 
system can be constructed to start in the ground state of a known (or solvable) objective function 
and then gradually shifted into the ground state of the objective function of interesting using the 
annealing coefficient, Γ: 
 𝐻(𝑡) = 𝐻1 + Γ(𝑡)𝐻" 2.15 
At the start of the optimization process, the annealing variable Γ is very large such that 𝐻(0) ≅
Γ(0)𝐻'. By the end of the optimization process, Γ(t) approaches 0 and the system is now in the 
lowest energy eigenstate of the Hamiltonian defined by the objective function of interest, 
𝐻(𝑡03:) ≅ 𝐻7. Thus, similar to simulated annealing, QA is guaranteed to find the global optimal 
solution if allowed to run long enough, and theoretical and experimental results suggest that QA 
boasts performance benefits over its classical counterpart, simulated annealing.70,71 
 Initial studies on QA were performed as simulations on classical computers72; however, 
classical simulation of this quantum process is computationally expensive and therefore 
impractical for higher order objective functions—such as those which would be necessary for 
many real-world problems. Quantum annealers are devices which use quantum hardware to 
physically realize the QA process. The major developer of quantum annealers to date is DWave 
INC. DWave quantum annealers use qubits which are made up of superconducting loops of 
current—the direction of the resulting magnetic field (down vs. up) defines the classical binary 
states of the qubit (0 vs. 1), but as quantum objects they can also exist in both states simultaneously. 
As of this time, DWave hardware supports a maximum of 2,000 qubits, which can represent 2,&&& 
unique states. 
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The earliest known application of quantum computing to medical physics was a study 
published in 2015 which investigated QA as a method for IMRT treatment plan optimization.73 In 
this study, IMRT beamlet weights for two prostate cancer cases were optimized using quantum 
annealer hardware and compared against two optimization methods—Tabu search and simulated 
annealing implemented on a standard classical computer.  
 Each algorithm was run for the same number of objective function evaluations, and 
performance was assessed by computational speed (defined as wall clock time), by the final 
objective function value, and by the overall quality of the treatment plans generated. For both 
cases, QA had a wall clock time that was more than twice as fast as simulated annealing and more 
than three times as fast as Tabu search. Simulated annealing was found to produce the highest 
quality plans for both cases, while the QA technique came in second and third, respectively. 
 One unique aspect of performing calculations on quantum-hardware is that problems must 
be formulated such that inputs and measured outputs are binary. In the case of the above study, 
each beamlet weight value was represented as a 5-bit vector, 𝑤; ∈
{[00000], [10000], [01000], … , [11111]	}, allowing for 2< = 32 levels of discretization. In total, 
each beamlet required 7 qubits for optimization: 5 to represent the numeric value and 2 for 
functional smoothing. It is important to note that when performing optimization with quantum 
hardware, the size of the solution search space is limited by the total number of qubits that the 
hardware can support. The QA device used in the above study supported 512 qubits. The authors 
therefore defined the beamlet dimensions such that ~70 beamlet weights were optimized for each 
plan. For clinical applications, however, a typical IMRT plan can have on the order of thousands 
to tens of thousands of beamlets—due to the use of more treatment beams (the study above used 
only 5) as well as smaller beamlet sizes. In addition, beamlet weights are usually represented as 
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(nearly) continuous variables, meaning each beamlet weight has a much larger range of potential 
values it can take. The most advanced quantum annealers as of the year 2020 support up to 2,000 
qubits; thus, technology is not yet at the point where it can support the full complexity of these 
types of optimization problems in radiation oncology. However, if quantum annealers are able to 
double the number of qubits they support every 2-4 years (as has historically been the case), then 
this may cease to be an issue within the next decade. 
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Chapter 3 A Quantum-Inspired Approach to Radiotherapy Optimization 
 
This chapter discusses the design and evaluation of a new quantum inspired optimization algorithm 
for radiotherapy treatment planning optimization and is based on the paper: Pakela J.M., Tseng 
H.H., Matuszak M.M., Ten Haken R.K., McShan D.L., El Naqa I. (2020), Quantum-inspired 
algorithm for radiotherapy planning optimization. Med. Phys., 47(1): 5‐18.  
3.1 Introduction 
Radiation therapy has been established as one of the primary modalities for cancer treatment, used 
either exclusively or in combination with other techniques such as chemotherapy or surgery.1,2 A 
critical challenge for radiation therapy (and all cancer therapies) is to deliver an adequate dose to 
the tumor to ensure curative or palliative results while minimizing the dose delivered to normal 
tissues. Intensity modulated radiation therapy (IMRT) is a type of external beam radiation therapy 
in which each beam is subdivided into a grid of beamlets whose intensities are determined by 
dynamic shielding via a multi-leaf collimator (MLC). Because IMRT and other radiation therapy 
techniques which rely on dynamic intensity modulation (such as Volumetric Arc Therapy 
(VMAT)) are capable of creating concave-shaped dose distributions, they are particularly effective 
for challenging cases in which the tumor volume is irregular and near critical organs at risk 
(OARs).3,4 The intensity modulations determined from this dynamic shielding optimization are 
characterized by aperture or beamlet weights. The challenge of calculating optimal weights for a 
treatment plan often represents a non-convex,5 large-scale optimization problem that must be 
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solved within a clinically reasonable timeframe. The ability to quickly perform robust 
optimizations is particularly significant in online adaptive radiotherapy, in which a patient’s plan 
may be reoptimized several times during the treatment course to account for changes such as tumor 
shrinkage or organ deformation.6 
Quantum computing research is believed to hold promise for achieving computational 
speedup for certain types of problems.7 In quantum computing, classical bits (whose two states are 
often represented by 0 and 1) are replaced by quantum bits (qubits) which may exist in any linear 
superposition of 0 and 1.8 This allows quantum computers to explore multiple solutions 
simultaneously, and quantum algorithms can take advantage of this to achieve a significant 
computational speedup.8,9 However, the direct use of quantum computers is still limited by 
challenges related to creating a proper hardware environment where qubits are maintained in 
quantum coherence7 and the number of qubits deployed is still limited (11-2,000)10-15 to effectively 
handle large scale optimization problems like planning optimization. On the other hand, quantum-
inspired algorithms also hold promise for achieving computational speedup of complex 
optimization problems. Such algorithms are not necessarily quantum processes per se (though 
some can be formulated to run on a quantum computer); rather, they are quantum simulations 
designed to run on a classical computer.  
The idea of incorporating quantum-inspired techniques into stochastic algorithms was first 
proposed by de Falco et al. in 1989.16 A few years later, Kadowaki and Nishimori demonstrated 
the use of quantum annealing (QA) on an Ising model of atomic spins by applying a transverse 
field, which was annealed to 0° and numerically solving the time-dependent Schrödinger equation 
for small systems; they found that the probability of reaching the ground state was consistently 
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higher for QA than simulated annealing (SA). Many studies have since ensued that have 
demonstrated QA’s potential for a variety of problems.16-20 
While QA holds theoretical promise for certain problem classes with limited 
dimensionality,21 its implementation on a classical computer is impractical for IMRT 
optimization19 and deployment on a quantum computer is currently hindered by the limited number 
of qubits built into existing hardware systems.19,21 To avoid these computational limitations, we 
have implemented another quantum-inspired optimization scheme that models the exploration of 
higher energy solutions based on the probability of a particle tunneling through a one-dimensional 
potential energy barrier. We refer to our algorithm as Quantum Tunnel Annealing (QTA) to 
distinguish it from the QA algorithms described by de Falco and others.16-22 In this paper, we 
present a proof-of-concept study that (1) demonstrates the behavior of QTA when applied to 
beamlet intensity and direct aperture optimization for IMRT treatment planning, and (2) compares 
QTA performance with that of SA as a representative benchmark of traditional optimization 
methods.  
3.2 Methods 
3.2.1 Quantum Tunnel Annealing 
QTA works by modeling an optimization problem as a biased random walk over a fixed number 
of iterations. During each iteration, a new potential solution (e.g., beamlet-weight vector) is 
selected from within the neighborhood of the current solution. The energy associated with the new 
potential solution, given by the objective function, is then calculated and compared against that of 
the current solution. Potential solutions with lower energies are immediately accepted and set as 
the current solution. A significant challenge associated with non-convex optimization problems is 
that the algorithm can become stuck in a local minimum before it has a chance to reach the globally 
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optimal solution. To avoid this pitfall and ensure adequate exploration of the solution space, QTA 
simulates quantum fluctuations, allowing the algorithm to accept a worse solution with some 
probability P. In this process, consider a quantum-particle with energy E, traversing through a one-
dimensional potential energy landscape, 𝑉(x). The particle’s wavefunction, Ψ(𝑥), obeys the time-
independent Schrödinger equation:  
 
 𝐻	Ψ(x) = 𝐸	Ψ(x), 3.1 
Where the Hamiltonian operator,	𝐻, is a function of the particle’s potential 𝑉 and kinetic energy 
𝑇: 
 𝐻 = 	𝑇 + 	𝑉. 3.2 
Figure 3.1 illustrates such a particle encountering a potential energy barrier (denoted 𝑉=). The 
particle’s wavefunction prior, during, and after encountering the barrier can be expressed as:  
 Ψ(𝑥) = 	e
𝐴𝑒"23 + 𝐴04"#$% ,		in	region	A










 𝑘 = 	q-:
ℏ'
(Γ − V7) , 	𝜅 = q-:
ℏ'
(V8 − Γ) , 𝑘0 =	q-:
ℏ'
(Γ − V9) .23 3.4 
A positive exponent represents the particle traveling to the right, and a negative exponent 
represents the particle traveling to the left. Thus, 𝐴(𝐴6)	and 𝐵(𝐵′) represent the amplitudes for the 
incident (reflected) waves in regions A and B, respectively, and C is the amplitude of the wave 
transmitted through the barrier. The probability of tunneling through the barrier is given by the 






. This value has suggested by Mukherjee and Chakrabarti to be 
on the order of 𝑒
!%&'(!')
*  using a Wentzel-Kramers-Brillouin (WKB) approximation.18,23  
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Figure 3.1: Figurative illustration of a particle (represented by its wave-function, Ψ) tunneling through a 
potential energy barrier (in region B) in a 1-dimensional energy landscape. 
 
Hence, the probability of QTA accepting a worse solution can be redefined to be proportional to 
exp }"	B∗DE+,%"	E-./
F
~	, where Γ is the kinetic energy of the system (an annealing variable 
synonymous with the temperature, T, in SA),	𝑉30B is the potential energy of the system at new 
solution defined by the objective function, and 𝑤 is the width of the barrier being tunneled through. 
This barrier width is a dynamic parameter, which serves as an additional degree of freedom that is 
not present in the SA formalism.   
3.2.2 Calculation of Barrier Width 
As stated in Section 3.2.1, the barrier width represents an additional degree of freedom, which 
QTA can use to obtain an optimal solution in a shorter timeframe. The expected trend in the barrier 
width’s evolution over the course of the optimization can be derived from the following argument: 
At the start of the optimization, energy barriers that the system encounters have finite widths; as 




In the interest of modeling the barrier width after a physical system in nature, one of the 
common barrier width schedules tested was modeled after the growth rate of Gallium Arsenide 
(GaAs) during the process of metal organic chemical vapor deposition (MOCVD). A typical 
MOCVD setup consists of a reaction chamber and a substrate material on a heated platform. As 
the substrate is heated by the platform, chemical reactions take place in the gas of the reaction 
chamber, leading to the growth of thin films upon the surface of the substrate. In a horizontal-type 
reaction chamber, the reactants are passed through the chamber horizontally. One of the most 
common semiconductors grown using MOCVD is GaAs.24 The growth of semiconductors using 
MOCVD is a complex process influenced by many parameters. It was shown experimentally that 
GaAs’s growth rate is proportional to the square root of the gas velocity.25  Given that kinetic 
energy is also proportional to the square root of velocity (i.e. Γ = )
,
𝑚𝑣,), we can express the 
growth rate as: 
 𝑑𝑤
𝑑𝑡
(𝑡) 	∝ 	 MΓ(t)( 	 3.5 
Where	𝑡 represents the annealing time defined as the iteration number, and Γ is the kinetic energy 
of the annealing system, defined in this study as: 









Figure 3.2: (a) Barrier width rate extrapolated from metal organic chemical vapor deposition (MOCVD) 
studies by Leys and Veenvliet.25 (b) Barrier width function calculated via numerical integration of (a). (c) 
Additional width functions explored in this study. 
 
The values corresponding to 𝑤(𝑡) were obtained using MATLAB’s numerical integration 
function, “integral()” and applying a proportionality factor (k); through trial and error, this was 
found to work well with  k=1 × 10"<. Both :B
:8
 and 𝑤(𝑡) with t ≤ 𝑁 = 5 × 10< iterations are 
displayed in Figure 3.2(a) and (b), respectively.  
Because QTA occasionally accepts worse solutions, it stands to reason that the barrier 
width does not grow continuously but rather experiences local width fluctuations combined with 
a globally increasing trend. Therefore, in addition to the MOCVD-inspired barrier width schedule, 
another schedule was also tested, defined as:  
 𝑤<(𝑡) = 𝑤=(𝑡) xsin-
50𝜋𝑡
𝑁




𝑤=(𝑡) = 	10 × M(𝑤0 ∗ 𝑡))  3.8 
With 𝑤6 > 0 used as a tunable parameter to control how quickly the width increases over the 
course of the optimization. The form of 𝑤G was chosen to introduce more local variations in the 
(a) (b) (c) 
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barrier width schedule in addition to the global trend of increasing width at a decreasing rate. This 
was done by coupling a fractional power function (given by 𝑤;) with a sinusoidal function. A 
squared sine function was chosen to ensure that the width was always at least as large as the global 
trend. For an annealing schedule where 𝑁 = 5 × 10<, the period of 10,000 corresponded to 10 full 
cycles during the search time.  
3.2.3 Simulated Annealing (SA) 
For comparison purposes, we used SA, a stochastic search algorithm, which was first introduced 
for IMRT optimization by Webb in 1989.1,26 Like QTA, SA models the optimization problem as 
a system which undergoes a biased random walk. Over the course of the random walk, the system 
will always accept new solutions, which improve on the old solution. In order to avoid getting 
trapped in local minima, the system accepts worse solutions with a probability proportional to 
exp 8"(E+,%"	E-./)
%
9, where 𝑇 is the temperature of the system that is annealed (decreased) over the 
course of the algorithm search. Mathematically, SA was proven to converge to a global optimal 
solution with minor assumptions on the cooling schedule and appropriate conditions on 
irreducibility, aperiodicity and reversibility of the induced Markov chain.27,28 Because SA has a 
long history of use in our clinic and the literature, it served as our benchmark algorithm for 
evaluating the success of QTA.29 The annealing schedule for T was identical to the schedule used 
for the QTA annealing variable, Γ, and is defined in Equation 3.6. Note that while the formalism 
of QTA shares many similarities with SA, the probability of accepting a worse solution in QTA 
differs from SA in two key respects: (1) reduced dependence on the potential energy difference 
between the current and new solution and (2) the presence of an additional dynamic parameter in 
the barrier width. These differences provide QTA with more freedom to explore the solution space. 
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3.2.4 IMRT Case Selection 
To analyze the performance of our quantum-inspired algorithm, we compared QTA and SA on 
two stereotactic body radiation therapy (SBRT) liver cases chosen from the University of Michigan 
Radiation Oncology Department’s clinical database.  
Case 1, a 12-field three-dimensional IMRT liver plan, was selected as an “easy” test case 
to confirm that both QTA and SA were performing properly. This case was not expected to pose 
a significant challenge for either optimization algorithm because it featured a minimal amount of 
overlap between the planning target volume (PTV) and the liver, and no overlap with other 
structures. For simplicity, the structures selected for optimization from Case 1 were the PTV and 
liver exclusive of the gross tumor volume (Liver – GTV) as shown Figure 3.3(a). Influence 
matrices for these structures were calculated using built-in functions defined in the Eclipse 
scripting application program interface (API). The voxel size used was 2 mm and the beamlet size 
was 5 mm x 5 mm, for a total of 158,720 voxels, 768 beamlets, and 1,602,504 nonzero elements 
in the dose influence matrices. 
Case 2 served as a “challenge” case to determine if the additional degree of freedom 
associated with QTA facilitated better results—such as plan quality, robustness, or speed—for 
more clinically relevant and difficult optimization problems. Designed as a 5-field IMRT plan, 
Case 2 was selected because it had significant overlap between the PTV, stomach, and liver 
structures as shown in Figure 3.3(b). Because this was a proof of concept study, only a subset of 
structures from the original treatment plan were included in our optimization. The structures were 
selected based on the priority assigned to them in the original clinical treatment plan. In addition, 
the dose volume histogram (DVH) constraints were also inspired by those used clinically. The 
influence matrices for these structures (3 mm voxel size, 2.5 mm x 5 mm beamlet size) were again 
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calculated using built-in functions available in the Eclipse scripting API. Note that smaller beamlet 
sizes were purposefully chosen for Case 2 to increase the number of optimization parameters. Case 
2 contained 79,977 voxels, 4166 beamlets, and 1,558,612 nonzero elements in the dose influence 
matrices. Because Case 2 contained more than four times more beamlet weights, it also represented 
a more challenging optimization problem than Case 1. The DVH constraints used in the 
optimization of Case 1 and Case 2 can be viewed in Table 3.1 and Table 3.2 respectively. 
 
 
Figure 3.3: CT scans show contours for structures optimized for Case 1 (a) and Case 2 (b), respectively. 
Case 1 features a PTV that is roughly spherical in shape and far from major organs. (with the exception of 

























Table 3.2: DVH constraints applied to objective function for Case 2. 
Case 2 DVH Constraints 
Structure Constraint Type Limit Volume (%) Dose [Gy] Penalty 
PTV DVH Point Lower 99 33 100 
 DVH Point Lower 95 30 200 
 DVH Point Lower 100 28 200 
 DVH Point Upper 0 48 160 
      
GTV Deformed MR DVH Point Lower 100 43 100 
 DVH Point Upper 0 48 160 
      
Liver - GTV Mean N/A N/A 4 50 
      
Stomach DVH Point Upper 0.001 28 150 
      
Stomach PRV DVH Point Upper 0.003 25 300 
 
3.2.5 Objective Function 
The objective function used for both SA and QTA IMRT optimization is defined by: 
 
Case 1 DVH Constraints 
Structure Constraint Type Limit Volume (%) Dose [Gy] Penalty 
PTV DVH Point Lower 100 29.7 50 
 DVH Point Lower 95 30 50 
 DVH Point Upper 0 60 100 
 Max Dose Range N/A N/A [30 42] 100 
      





subject to 𝒃	 ≥ 0 
3.9 
Where:  

















 𝒅/(𝒃) = 𝑰/ ∗ 𝒃.  3.11 
The first term in the objective function represents the mean squared error between the prescribed 
dose, 𝑫3, and the delivered dose, 𝒅3(𝒃), for each structure 𝑛 of N structures. 𝒅3(𝒃) represents the 
dose delivered to each voxel in structure 𝑛,	and is defined in Equation 3.11 as the product of the 
structure’s influence matrix,	𝑰3, and the beamlet-weight vector, 𝒃. 𝑱3	is the number of voxels in 
structure n. The influence matrices for each structure were calculated using the Eclipse Scripting 
API’s built-in “CalculateInfluenceMatrixToMemory()” function. The point cloud which was input 
into this influence matrix function was calculated using an in-house script that generates a 
normally distributed random set of point locations whose average distance is the cube root of the 
desired voxel size. 
For an influence matrix I, matrix element Iij is defined as the dose contribution to voxel i 
from beamlet j. Any given beamlet is expected to contribute primarily to the voxels it overlaps 
with and their nearest neighbors. However, due to scattering effects Eclipse-generated influence 
matrices contain no non-0 values; they contain a subset of elements whose values are orders of 
magnitude smaller than the largest values in the matrix—corresponding to a beamlet’s contribution 
to a distant voxel. To facilitate faster optimization, a tolerance value was defined below which 
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influence values were deemed negligibly small and reset to 0. This allowed for the influence 
matrices to be saved as sparse matrices, reducing calculation times. An acceptable tolerance value 
was determined by trial and error to be 0.015—this was done by loading fluence vectors that were 
optimized using filtered influence matrices into the Eclipse scripting API, performing MLC leaf 
sequencing and dose volume calculation, and comparing the resulting DVH histograms with those 
produced in-house. 
The second term in objective function represents a smoothing penalty which was 
implemented to ensure the treatment plans could be delivered efficiently. In order to determine the 
optimal filter, 𝑳, a series of QTA optimizations were performed on Case 2 using a number of 
different filter types—including median, Savitzgy-Golay (SG), plan intensity map variation 
(PIMV), and Laplacian and Laplace of Gaussian (LOG) filters with kernels of sizes 3, 5, 7, 9, and 
15, respectively.30 For the smoothing filters, a penalty value was defined as the squared difference 
between the original and smoothed fluence map. For the PIMV-type filter, the square of the PIMV 
value for each beam was used as the penalty. For the edge-finding filters of kernel size n, the filter 
kernel was convolved with the beamlet matrix 𝑩H (reshaped from the beamlet weight vector) for 
each beam. The squared sum of the indices of the resulting matrix yielded a value correlated to the 
degree of irregularity for each beamlet matrix. With the exception of the Laplace filter and the 
PIMV filter, all filters tested were implemented using MATLAB built-in functions. Each filter’s 
performance was evaluated by visually inspecting fluence maps and comparing the total number 
of monitor units (MUs) necessary after MLC leaf sequencing.  
The third term in Equation 3.10 represents additional penalties based on DVH constraints 
associated with each structure. The dose constraints and penalties, 𝑷3, used in each case can be 
viewed in Table 3.1 and Table 3.2. For Case 1, simple Boolean conditions were used to assign 
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penalty values (for example, if 99% of the PTV receives < 33 Gy, add 100 to the DVH penalty). 
The weighting factors 𝜶3 used in Case 1 were set to 1 for all structures. For the more challenging 
Case 2, we found it necessary to adjust the calculation of the DVH penalty. Specifically, for Case 
2, penalties for missed DVH constraints were assigned as the penalty value (listed in the last 
columns of Table 3.1 and Table 3.2) multiplied by the absolute difference between the DVH 
constraint and the actual metric achieved. For example, if 99% of the PTV volume received ≥ 29 
Gy, the penalty for that constraint would be (30-29)	× 100. Because the constraint type is 
designated as “lower,” no penalty is assigned if 99% of the PTV volume receives > 33Gy. Finally, 
for Case 2, 𝜶I%E and 𝜶J'K0L"M%E were set to 9 and 10, respectively. 
3.2.6 Extension to Influence-based Direct Aperture Optimization 
In addition to fluence map optimization, the objective function described in Section 3.2.5 can be 
generalized to directly optimize apertures (defined by MLC leaf positions) and their weights using 
a method known as influence-based direct aperture optimization (DAO).31,32 This is accomplished 
by defining the fluence weights as a function of the MLC leaf segment positions and aperture 
weights, which for small beamlets can be written as:  
 𝒃(𝒍,𝒘) = 	∑ 𝑻(𝒍)𝒊 ×𝒘"" , 3.12 
Where 𝒍 defines the MLC leaf positions, 𝒘' 	is the weight assigned to aperture i, and 𝑻(𝒍)' 	is a 
transmission matrix whose values represent the fraction of each beamlet unobstructed by the MLC 
leaf segments for aperture i.31 
3.2.7 Criteria for Convergence 
In order to compare QTA and SA’s performance in a faithful manner, it is necessary to develop a 
quantitative method for defining convergence. For both optimization methods, the energy at each 
iteration t was saved in a vector, E(t). The gradient of E(t) was calculated numerically in 
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MATLAB. From this gradient, a moving average mean (MAM) with width 100 was then 
calculated. A tolerance value, ctol, was selected by trial and error, and the largest index position, j 
(for which |MAM(j)| > ctol) was identified. The convergence point for the algorithm was then 
defined as iteration j+1. Figure 3.4 displays the process of finding the j (and thus j+1) from E(t). 
An appropriate value for ctol was found to be 0.1.  
 
Figure 3.4: Process of calculating the convergence iteration number from a representative QTA 
optimization. The saved energy history is represented by (a), and is used to calculate the energy gradient 
((b)). From this gradient a MAM of width 100 was calculated ((c)). The black vertical line is plotted at the 
maximum iteration number j for maxj(|MAM(j)| >ctol).  
 
3.2.8 Computing Environment 
All beamlet-weight optimizations described in this paper were performed using MATLAB scripts 
with graphics processing unit (GPU) acceleration on the University of Michigan’s High-
Performance Computing Linux-based cluster, Flux (central processing unit (CPU): Intel Haswell, 
GPU: Nvidia K40). Each job was submitted with 2 CPU cores (4 GB/core) and 1 GPU. 
MLC leaf sequencing and dose volume calculations used for final plan visualization were 
performed using clinical software (Varian Medical Systems, Inc. Eclipse Treatment Planning 
System: Varian Leaf Motion Calculator Version 13.6.23, Anisotropic Analytical Algorithm 
Version 15.5.11). 
(a) (b) (c) 
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The complete QTA algorithm for IMRT optimization is summarized in Figure 3.5. The 
maximum possible number of iterations performed in each run was defined as 𝑁 = 5 ∗ 10<. 
Because the parameter N was used as a variable in both the annealing schedule (T or Γ) and the 
barrier width schedule (w), its value was not altered over the course of the reported studies. 
Therefore, in order to vary the actual number of iterations performed, an additional break 
parameter was defined which forced the algorithm to end early at iteration n = nbreak. This break 
parameter was implemented both to shorten the duration of optimizations when it was clear an 
optimal solution had been reached prior to N as well as to confirm that the convergence iteration 




Figure 3.5: Quantum Tunnel Annealing (QTA) algorithm for intensity modulated radiation therapy (IMRT) 
optimization. 
Algorithm 1: QTA
Initialize: bsolution  b0;
V (b) :=
PN




ij |(L ⇤Bm)ij |2 +PN
n=1 ↵nPn(b,DV Hconstraints) ;
d(b) := I ⇤ b;
w  w0;
T  T0;
for Iij in I do




for n 1 to Nmax do
Tn  T0(1  log(n)/log(N));
wn  wn+1;
bn  max(0, bn + rneighbor);
if n = nbreak then
bsolution  SGfilter(bsolution);
for bi in bsolution do

















if n = N then
bsolution  SGfilter(bsolution);
for bi in bsolution do











3.3.1 Case 1 
Preliminary studies on a geometrically simple case, designated “Case 1,” confirmed that the QTA 
and SA algorithms were performing properly. Figure 3.6(a) through (d) displays the DVH and 
potential energy (PE) trajectory results acquired by running the QTA and SA algorithms 20 times 
each for 𝑁 = 5 × 10< iterations and no premature breaks (i.e., nbreak > N). Figure 3.6(e) through 
(f) displays representative dose distributions for QA and SA, respectively, which were calculated 
in Eclipse using optimized beamlet-weights from the tenth run. For Case 1, the incorporation of a 
Laplace edge-finding filter with a kernel size of 3 into the objective function was found to yield 
sufficiently deliverable plans. Beamlet-weights generated from both QTA and SA were found to 
consistently yield plans that satisfied the DVH constraints.  
The DVH curves for QTA (Figure 3.6(a)) and SA (Figure 3.6(b)) indicate that for case 1, 
QTA exhibited greater stability over SA with respect to the quality of the final plan. SA converged 
to a solution with worse PTV coverage 60% of the time. Figure 3.6(c) and (d) display the PE 
trajectories for the QTA and SA runs, respectively. The PE trajectories for QTA indicate that QTA 
explored higher energy solutions prior to sudden extreme drops around the (𝑛	 = 	1 × 10<)th 
iteration, whereas SA featured a more linear decrease. The resulting dose distributions were found 
to be similar between both algorithms and featured reasonable tumor coverage while minimizing 





        
Figure 3.6: Optimization results for QTA and SA applied to Case 1. (a) and (b) display DVH curves for 10 
separate optimizations using QTA and SA, respectively. (c) and (d) display the PE trajectories for the 10 
QTA and SA optimizations. (e) and (f) display representative dose distributions calculated in Eclipse using 
fluence values from the 10th QTA and SA optimization. 
 
3.3.2 Case 2: Redefined Smoothing Filter 
In the pursuit of designing an objective function that can produce clinically acceptable and 
deliverable plans, a comprehensive study (described in detail in Section 3.2.5) was performed to 





Smoothness was assessed qualitatively using the fluence maps and quantitatively using the total 
MU required (summed over each beam). Figure 3.7(a) displays the optimized fluence map for one 
of the Case 2 beams using a LOG filter within the objective function. The speckled appearance of 
Figure 3.7(a) suggests that smoothing within the objective function alone is not sufficient, and the 
MU necessary for this plan was more than 20% larger than predicted for an Eclipse-optimized plan 
which met the same DVH constraints. Adjustments to the size of the kernel and the type of filter 
used within the objective function did not yield discernable improvement to fluence regularity or 
total MU. 
We also explored directly applying a smoothing filter to the beamlet weights outside of the 
objective function. We found that the optimal smoothing process consisted of the 7x7 LOG filter 
within the objective function, combined with a two-dimensional SG filter applied to the beamlet-
weights during the final iteration of the algorithm. The optimized fluence map using this refined 
smoothing filter is displayed in Figure 3.7(b) and appears markedly smoother than the LOG-filter 
alone. This refined smoothing filter resulted in a total of 2877 MU, which was 34% lower than the 
LOG filter alone and more than 20% lower than the Eclipse-optimized plan. The plan quality, as 




Figure 3.7: (a) displays the fluence map results for a single beam in Case 2 resulting from the QTA 
optimization without refined smoothing. (b) displays the fluence map results from QTA optimization with 
refined smoothing. 
 
3.3.3 Case 2: Barrier Width Schedule Effect 
As discussed in 3.2.2, four different barrier width schedules were investigated for QTA. One was 
inspired by the growth rate of GaAs in MOCVD, while the remaining three were designed to allow 
for local fluctuations in the barrier width within a globally increasing trend. Table 3.3 lists 
convergence rates calculated for QTA optimizations using the four barrier-width schedules as well 
as optimizations for SA. Three of the four barrier widths tested yielded convergence faster than 
SA. The optimal barrier width schedule was found to be the 𝑤< function with 𝑤6 = 1 × 10"<, and 









Table 3.3: Convergence times (in seconds) for QTA with different barrier width schedules as well as SA. 
Case 2 Convergence Results QTA Barrier Width Testing 
Algorithm type Convergence (s) 
SA 1062.5 
QTA, 𝑤< , 𝑤0 = 1 × 106G 528.6 
QTA, 𝑤< , 𝑤0 = 1 × 106H 637.2 
QTA, 𝑤< , 𝑤0 = 1 × 106I 1762 
QTA, MOCVD 874.2 
 
3.3.4 Case 2: Annealing Schedule Effect 
Each algorithm’s sensitivity to the choice of annealing schedule was assessed by comparing their 
performance across five different functions (shown in Figure 3.8(a)): T1, a linear function; T2, a 
sigmoidal function; T3, an exponential function; T4, a logarithmic function; and T5, a power law 
function with fractional exponent. Figure 3.8(b) displays box and whisker plots of the convergence 
rates for QTA and SA respectively for each annealing schedule. For schedules T1, T2, and T3, SA 
failed to reach convergence prior to the breakpoint at 𝑛;L0G> = 2.5 × 10<, resulting in the tight 
spread of data for SA at these schedules. QTA exhibited lower average convergence rates for all 
five annealing schedules. Note that for this paper, T4 (defined by Equation 3.6) served as the 
default annealing schedule because it was found to yield reasonable optimization results during 




Figure 3.8: Displays the annealing schedule functions tested for QTA and SA. Note that T4 was the 
annealing schedule used for all remaining studies. (b) displays box and whisker plots of the convergence 
results for QTA and SA, respectively, for each annealing schedule. 
 
3.3.5 Case 2: Optimization Stability 
QTA’s stability was verified by performing a series of optimization tests using different starting 
beamlet-weight vectors (10 runs per initial beamlet-weight vector tested, 𝑁 = 5 × 10< iterations, 
which ran until 𝑛;L0G> = 2.5 × 10<). As a comparison, SA optimizations were also performed 
under the same conditions. The optimizations began with initial beamlet-weight vector values set 
to 0, 11, and 20, respectively. These values represent the minimum, average, and maximum fluence 
values expected for the optimized beamlet-weight vector. In addition, tests were also conducted 
using an initial beamlet-weight vector whose values were randomly distributed over a range from 
0-20. In order to assess whether QTA is primarily advantageous later in the annealing schedule 
after the algorithm has become stuck in local minima, additional tests were performed on a hybrid 
SA-QTA algorithm, which ran SA for the first 5 × 10N	iterations after which the algorithm 
switched to QTA. The initial beamlet-weights used for the hybrid tests were also randomly 
distributed over a range from 0-22. 
(a) (b) 
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Figure 3.9 displays the results for 10 QTA and SA optimizations using the randomly 
distributed initial beamlet-weight vector. The DVH curves for QTA (Figure 3.9(a)) and SA 
(Figure 3.9(b)) suggest that both reached final solutions with nearly identical dose coverage. This 
finding was found to hold for all iterations regardless of the initial beamlet-weights used. The 
energy trajectories for QTA (Figure 3.9(c)) and SA (Figure 3.9(d)) are plotted on a Log scale to 
highlight differences in the shape of the curves. Like Case 1, the QTA PE trajectories for Case 2 
feature a region of rapid descent, located just after the 103 iteration. All QTA and SA runs (for b0 
= 0,1,20, and rand) required ≥ 1.1 × 10< iterations to reach convergence. Figure 3.9(e) and (f) 
display the Eclipse-calculated dose distributions from the tenth optimization for QTA and SA, 
respectively. The final dose distributions were found to be nearly identical and exhibited 













        
Figure 3.9: DVH bands, PE trajectories, and representative dose distributions for stochastic optimizations 
(N = 10, 500000 iterations) with the initial beamlet-weight vector set to random values uniformly distributed 
between 0 and 22 on a challenging SBRT liver case for QTA ((a), (c), and (e)) and SA ((b), (d), and (f)), 
respectively.  
 
Table 3.4 displays the mean convergence rates (in seconds) for QTA, SA, and the hybrid 






deviations than SA in all but one case (b0 = 11). The convergence rates of the SA-QTA hybrid 
algorithm were similar to the performance of SA. 
 
Table 3.4: Mean convergence times (in seconds) for QTA and SA with perturbations to the initial beamlet-
weight values. 
Case 2 Convergence Results for Initial Beamlet-Weight Testing 
b0 QTA (s) SA (s) SA-QTA hybrid (s) 
0 637.9	±	63.2 982.4	± 96.3 N/A 
11 644.8	± 84.4 987.4	± 82.1 N/A 
22 693.2 ± 75.9  1103 ±	84.0 N/A 
Randomly distributed 611.0	± 72.4 996.4 ±	103.0 953.1 ±	65.5 
 
The stability of QTA and SA was also assessed by making perturbations in the original dose 
constraints. For each of these tests, a perturbation was made to a single constraint while all others 
were held constant. Each optimization was run for 𝑁 = 5 × 10< iterations and stopped at 
𝑛;L0G> 	= 	2.5 × 10<.  
 
Table 3.5 summarizes the perturbations tested and the corresponding convergence rates (in 
seconds). For all perturbation types, QTA exhibited faster convergence. However, the percent 
difference in the perturbed convergence rates from the original convergence rate ranged from 




Table 3.5: Parameter changes and convergence times (in seconds) for QTA and SA with perturbations to 
the original dose constraints. 
Case 2 Convergence Results for Parameter Testing 
Parameter  Organ from to QTA (s)  SA (s) 
DVH Stomach Max dose = 28Gy Max dose = 18Gy 788.8 1038.9 
DVH  Liver Mean dose = 4Gy Mean dose = 2Gy 951.6 1108.2 
DVH and Dose PTV Target dose = 33Gy Target Dose = 43Gy 701.2 1028.6 
Original Original N/A N/A 661.8 1083.3 
 
3.3.6 Aperture-Weight Optimization via Influence-Based DAO 
Influence-based DAO was performed on QTA and SA for 10 runs per initial beamlet-weight vector 
tested (𝑁 = 5 × 10< iterations running until 𝑛;L0G> = 2.5 × 10<) using the fluence approximation 
formalism described in 3.2.6. For these optimizations, leaf segment information was extracted 
from a pre-existing Eclipse-optimized IMRT plan (with a total of 431 apertures) on Case 2, and 
aperture weights were optimized with the starting weight of each aperture set to 0. Figure 3.10 
displays the resulting cumulative DVHs ((a) and (b)), potential energy trajectories ((c) and (d)), 





        
Figure 3.10: DVH bands, PE trajectories, and representative dose distributions for stochastic optimizations 
(N = 10, 250000 iterations) of aperture weights on a challenging SBRT liver case for QTA ((a), (c), and 
(e)) and SA ((b), (d), and (f)), respectively.  
 
The DVHs displayed in Figure 3.10(a) and (b) indicate that QTA and SA achieved 
comparable tumor coverage and OAR sparing. While the energy trajectories in Figure 3.10(c) and 
(d) indicate that QTA exhibited more stochastic exploration of the solution space early on in the 





convergence rate of 7,151 ±	504.5 (s). Figure 3.10(e) and (f) show that both algorithms also 
produced similar dose distributions.  
3.4 Discussion  
The optimization results from Case 1 confirmed that both algorithms were capable of delivering 
clinically acceptable results. QTA was found to be more stable than SA with regard to the quality 
of the final solution to which it converged, as SA converged to a worse solution 60% of the time.  
Because it was more geometrically complex, Case 2 was used to characterize QTA’s 
performance. One of the ways QTA distinguishes itself from SA is that the probability of accepting 
a worse solution during the course of the optimization is a function of the estimated width of the 
potential energy barrier, providing an additional degree of freedom with which to explore the 
solution space. We tested several expressions which were heuristically selected to represent the 
barrier-width function. Adjusting the form of the barrier-width function did not influence the 
quality of the final plan if the algorithm was allowed to run for its fully allotted time. However, 
the form of the barrier-width function did influence how quickly the algorithm reached 
convergence. The convergence results listed in Table 3.3 suggest that the barrier-width function 
can be used as a tunable parameter to achieve faster convergence. While further tests are warranted 
to determine an optimal expression for the barrier width, the majority of the functions tested 
yielded faster convergence rates than SA. 
The convergence rates of both algorithms were found to be dependent on the annealing 
schedule chosen. For three of the five functions tested, SA failed to converge 30-80% of the time, 
while QTA reached convergence for all five evaluated functions. In addition, QTA had faster mean 
convergence rates for all five annealing functions tested. These results suggest that QTA is more 
robust against the choice of annealing schedule. Another way to conceptualize this advantage is to 
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interpret QTA as having a modified annealing schedule in which the barrier width function serves 
as an additional time-dependent, tunable parameter, coupled with a dampened dependence on the 
energy difference between the current and new solution. 
Testing the sensitivity of QTA with respect to changes in the initial beamlet-weights, b0, is 
useful for determining whether the algorithm can reliably deliver clinically acceptable plans under 
conditions where a “good” first guess is unknown. In initial beamlet-weight tests (described in 
Section 3.2.4) we found that QTA consistently achieved faster convergence times over SA across 
all variations of b0.  
Unlike Case 1, Figure 3.9(a) and (b) suggest that both QTA and SA consistently achieved 
final solutions of nearly identical plan quality for Case 2. These findings held even after varying 
the initial starting guess. These results may seem surprising given that Case 2 represented the more 
challenging case. The explanation lies in the difference between the objective functions used for 
Cases 1 and 2, which are described in detail in Section 3.3.5. Case 1 penalties based on the DVH 
constraints were assigned using Boolean conditions. Implementing the DVH constraint portion of 
the objective function was found to be insufficient for Case 2 because it could not provide 
sufficient PTV coverage without delivering an excessive dose to the organs at risk. Therefore, 
when we began working on Case 2, it was necessary to adjust the objective function so that 
penalties based on the DVH constraints were weighted more heavily as plan results strayed farther 
from the objectives. The difference in results between Case 1 and Case 2 suggest that the additional 
constraints applied to Case 2’s objective function narrowed the solution space available to the 
algorithms. In light of this point, the combined results from both cases suggest that QTA is more 
robust than SA to changes in the formulation of the objective function. 
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To assess QTA’s sensitivity to changes in treatment plan goals, a series of optimizations 
were run for QTA and SA in which perturbations were made to the PTV dose prescription and to 
OAR dose constraints. It was found that while QTA continued to achieve faster convergence rates, 
those rates exhibited greater variation from the original, unperturbed convergence rate.  
For Case 2, it was found that implementing smoothing only within the objective function 
was insufficient for producing plans with clinically deliverable fluence maps. This is likely due to 
the algorithms’ stochastic nature and the fact that Case 2 contained more than four times the 
number of beamlets as Case 1. Ultimately, a refined smoothing technique was developed which 
combined a LOG filter—used to define an irregularity penalty in the objective function, with a 
two-dimensional SG filter that was applied to each beamlet map during the final iteration. The 
resulting fluence maps for these plans had total MU values which were more than 20% less than 
those for an Eclipse-optimized plan. It is perhaps unorthodox to include a smoothing filter outside 
of the objective function, as this can compromise plan quality.30 However, we found that 
implementing the SG filter during the optimization’s final iteration had only a small impact on 
plan quality, and all plans generated using this technique were comparable in quality to plans 
generated using Eclipse-based IMRT optimization.  
In order to further investigate the potential of QTA over SA, it is necessary to test additional 
optimization formalisms with known ill-behavior. One such representative approach is to estimate 
the aperture weights directly using the influence-based DAO approach described in Section 3.2.6. 
DAO was evaluated on the more complex Case 2. The results from these optimizations (presented 
in Section 3.3.6) indicate that on average QTA converged up to 26.8% faster than SA. DAO is a 
more complex optimization problem than fluence optimization. While the results of this study 
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example may suggest that the performance gap between QTA and SA seemingly becomes 
narrower, QTA still exhibits notable benefits over SA overall. 
The limitations of this study are summarized as follows: Because only two patient cases 
were considered, our knowledge of the algorithm’s sensitivity to different cases is still limited. We 
chose to only optimize the most challenging and critical structures in each case; for this reason, 
the convergence times reported are not representative of a full treatment plan. In addition, the 
expression used in QTA to define the probability of a particle tunneling through a potential energy 
barrier contains weaknesses in its assumptions about the size of the annealing variable, Γ. Due to 
these assumptions, while the formulation for QTA can be described as quantum-inspired, it does 
not represent a true simulation of a quantum process. Nevertheless, QTA was found to exhibit 
several qualities that suggest it might be an attractive candidate for applications which necessitate 
rapid optimization of complex or challenging treatment plans. QTA consistently performed faster 
than SA across multiple types of perturbations and yielded treatment plans of equal quality. 
Furthermore, a hybrid SA-QTA algorithm was found to perform only slightly better than SA alone, 
reinforcing the merit of the full QTA algorithm. The presence of an additional degree of freedom 
represented by the barrier width schedule leaves open the possibility that this parameter might be 
further fine-tuned to achieve even faster results.  
The results of this study suggest that the extra degree of freedom associated with QTA’s 
barrier-width schedule allowed for the algorithm to be better “tuned” to converge at faster rates 
than SA. Natural future directions for this work include performing QTA optimizations on full 
IMRT treatment plans and VMAT plans, which represent a larger optimization problem. Based 
QTA’s computational speedup and ability to escape local minima, it may be a useful tool for 
computationally demanding adaptive radiotherapy applications. Finally, QTA would be a valuable 
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tool for implementing more complex (typically non-convex) objectives based on biological 
optimization objectives combining imaging and molecular biomarkers with dose-response 
functions derived via multiple outcome and utility modeling methods,33,34 which as of now are 
hindered in clinical implementation by a lack of efficient and robust optimization techniques. 
In addition to further studies applying QTA to more challenging treatment problems, we 
would also like to explore whether implementing QTA on a quantum computer could lead to 
greater computational speedup. In their 2015 study, Nazareth and Spans reported on the first use 
of a quantum annealing computer for IMRT beamlet weight optimization; they found that while 
SA consistently produced higher quality plans, optimizations performed on a quantum annealing 
device (using a modified version of Tabu Search as the optimization algorithm) were >2.5 times 
faster than SA.19 At the time of their study, the researchers were limited to a 512 qubit device, 
which restricted the complexity of the treatment problems they could tackle. For reference, if the 
beamlets in Case 1 were discretized using the same method used by Nazareth and Spaans, 5,376 
qubits would be required. In early 2019, the development of a 5,000 qubit commercial quantum 
annealing computer was announced,35 which would better allow QA to be scaled to higher variable 
optimization problems but practical clinical application remains a subject for future studies. We 
believe QTA would be an exciting candidate for quantum computing because it has already shown 
promise over SA when run on a classical computer. 
3.5 Conclusions 
In this study we have explored the behavior of a novel algorithm inspired by quantum tunneling, 
QTA, for use in IMRT beamlet-weight optimization on two SBRT liver cases. We compared 
QTA’s performance with classical SA, an algorithm which has historically been used for this 
application. On the easier case, QTA exhibited greater stability than SA. On the challenging case, 
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when allowed to run for the fully allotted number of iterations, both algorithms performed well 
and exhibited stability with respect to plan quality. With regards to the differences observed 
between Case 1 and Case 2, it is worth noting that the primary benefit of QTA in a more 
constrained solution space is the speedup at which it converges, while in a larger (i.e., less 
constrained) solution space, QTA appears to achieve both faster convergence and plans of more 
robust quality. These results suggest that QTA may have promise in application to more complex 
objective functions, such as those defined by biological predictive models. Extension to DAO is 
demonstrated to be feasible with similar performance, suggesting potential application of QTA for 
VMAT type applications as well.  
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Chapter 4 Dynamic Stochastic Deep Learning Approaches for Predicting Geometric 
Changes in Head and Neck Cancer 
 
This chapter discusses the design and validation of two novel frameworks employing quantum 
mechanics and Markov models, in combination with deep recurrent neural networks, for predicting 
patient geometric changes across fractionated radiotherapy. It is based on the paper: Pakela, J. M., 
Matuszak, M. M., Ten Haken, R. K., McShane, D. L., El Naqa, I. (expected early 2021) Dynamic 
Stochastic Deep Learning Approaches for Predicting Geometric Changes in Head and Neck 
Cancer. (under processing). 
4.1 Introduction 
4.1.1  Adaptive Radiotherapy  
Radiation therapy (RT) has been widely established as the standard of care for numerous cancer 
types, with as many as 50% of cancer patients who receive RT as part of their treatment each year.1 
Innovations in treatment delivery, such as the use of multi-leaf collimators during intensity 
modulated radiation therapy (IMRT) and volumetric arc therapy (VMAT) to dynamically move 
and shape the beam during treatment, have made it possible to achieve dose distributions which 
conform tightly around the tumor with steep dose gradients, allowing for the delivery of higher, 
more curative doses to treat the disease while minimizing the dose delivered to the surrounding 
healthy tissues.2,3 
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Despite these advancements, a challenge remains in that over the course of fractionated 
treatment, factors such as weight loss, tumor shrinkage, or daily anatomical variations can cause 
geometrical changes in the patient’s anatomy such that the original treatment plan is no longer 
optimal—either due to inadequate target coverage or due to increased exposure to organs at risk 
(OARs). Clinics often track anatomical changes through daily cone-beam computed tomography 
(CBCT) images taken prior to each treatment; if a patient’s plan is deemed to stray too far from 
the original treatment objectives, alterations can be made, which at their most extreme involve a 
full replan. The process of using imaging data to make adaptations to a patient’s plan during 
treatment is called image-guided adaptive radiotherapy (IG-ART).  
While IG-ART has been shown to improve the accuracy and quality of patient treatment 
plans,4,5 several challenges continue to inhibit wider implementation:  
1. Clinical time and resource constraints necessitate that IG-ART methods be efficient.6  
2. In addition, because CBCT images suffer from higher noise and a limited field of view,7 
daily anatomical changes can be difficult to quantify with accuracy, necessitating IG-
ART plans to be robust to measurement uncertainties. 
3. Finally, while it has been shown that IG-ART can improve treatment accuracy, there 
exists no standardized set of criteria for how much a patient’s plan needs to deviate 
from its intended objectives in order to trigger the use of adaptive radiotherapy (ART) 
methods.8 
A consequence of these challenges and their time-consuming processes is that some patients do 
not undergo necessary plan adaptations who might otherwise benefit from them to optimize their 
treatment outcomes. One approach which addresses the first of these obstacles is to develop a 
framework which, based on relevant patient characteristics, predicts the likelihood of patient 
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anatomical changes occurring in future fractions. Such a framework would allow for a proactive 
approach to ART in contrasts to passive image deformation approaches, effectively buying time 
for busy clinics by allowing them to anticipate and prepare for plan adaptations before they actually 
occur. 
4.1.2  Predictive Models for ART 
The development of predictive models to aid in decision making for ART is an active research 
topic. Predictive models typically utilize imaging data (image-guided models) and/or clinical, 
dosimetric, biological, and radiomic data (knowledge-based models).9 Given the prevalence of 
daily imaging for patient setup, models based on image guidance are arguably the easiest to 
implement into a clinical workflow.  
There is currently no set consensus regarding what types of predictions are most valuable 
or necessary for an ART paradigm. Recent studies have reported on models for predicting tumor 
control probability (TCP) / normal tissue complication probability (NTCP),10,11 dosimetric 
deviations from the original treatment plan,12 as well as incidence of radiation-induced toxicity13 
and tumor failure.14 This variety of approaches is due in part because the objectives for 
implementing ART may differ across cancer type and/or treatment clinic and can vary from 
improving dosimetric accuracy, reducing tumor failure, or preventing specific radiation-induced 
toxicities such as radiation pneumonitis or xerostomia. Adding to this challenge is that there is still 
an incomplete understanding between the relationship of anatomical/dosimetric deviations during 
treatment and clinically meaningful outcomes.15 
Recent studies have also reported on the use of geometric anatomical changes (measured 
via computed tomography [CT] imaging) as a condition for triggering plan adaptation and linked 
anatomical changes to significant, undesirable dosimetric outcomes.16,17 However, to date there 
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has been limited work towards trying to predict geometric changes during radiotherapy, and the 
only known existing study is limited both in sample size (N=23) and the ability to predict beyond 
the next day’s fraction.18 
4.1.3 Quantum Predictive Models and Quantum Processes 
Recent work has found that quantum mechanics can be applied successfully as a predictive 
framework for systems outside of fundamental physics—namely human cognition and decision 
making.19 In the next two sections we provide a brief review of the quantum predictive framework 
as well as the Markov predictive framework. 
At the turn of the 20th century, scientists began to observe phenomena in nature which 
violated the laws of classical physics—notably the behavior of light and thermodynamic 
systems.20,21 Quantum mechanics is the mathematical framework which was developed as a means 
to describe and understand this strange behavior.  
The first three postulates of quantum mechanics can be formulated as follows22: 
1. A quantum system can be fully described by its unitary state vector, which can be written 




Where the set of vectors |𝑣'∈P⟩ form an orthonormal basis in a finite N-dimensional Hilbert space. 
The notation "|		⟩" is called a ket and represents a column vector in a complex vector space. 
Conversely, "⟨		|" is called a bra and represents a row vector, such that |𝑣⟩	is the conjugate 
transpose of ⟨𝑣| (i.e., ⟨𝑣|5 =	 |𝑣⟩	). The coefficients, 𝑎' in Equation 4.1 are called probability 
amplitudes because the probability of a quantum system, |𝛹⟩, being observed in state |𝑣'⟩ is given 
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Whose solution takes the form: 
 |𝛹(𝑡 + 𝑛)⟩ = U(t + n)|𝛹(𝑡)⟩ 4.4  
 
 𝑈(𝑡 + 𝑛) = 	𝑒6"(J(/)K 4.5  
Where |𝛹(𝑡)⟩ is the state at time, 𝑡, and 𝑈(𝑡 + 𝑛) is a unitary transition matrix defined by a 
Hermitian operator, 𝐻, called the Hamiltonian. In physics, the Hamiltonian represents the total 
energy of the system. (Note that in Equation 4.5, Plank’s constant (denoted by ℏ) has been 
absorbed into 𝐻.) 
3. A measurement on a quantum system is conducted by applying a measurement operator, 
𝑀H, to the system state vector. The index, 𝑚, spans each of the possible outcomes of the 
measurement such that: 
 G𝑀:L𝑀:
:
= 	𝐼 4.6  
Where 𝐼 is the identity matrix. The probability of obtaining a measurement outcome 𝑚 on a 
quantum system described by |𝛹⟩ is given by: 
 𝑃(𝑚) = |𝑀:|𝛹⟩	|- =	 ¡𝛹𝑀:L𝑀:𝛹¢ 4.7  
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4.1.4 Classical Markov Processes 
A Markov process refers to a classical stochastic process which has no memory of its past and is 
influenced only by its current state.23 Given a finite number, 𝑁, of potential states, the state 
probability distribution can be written as an 𝑁 × 1 column vector, 𝑀(𝑡). Each entry of 𝑀(𝑡) 
represents the probability of finding the system in a given state at time 𝑡, such that: 
 G𝑀"(𝑡) = 1
"
  4.9 
Similar to a quantum process, a Markov process evolves over time according to a transition matrix, 
𝑃(𝑡), such that: 
 𝑀(𝑡) = 𝑃(𝑡)𝑀(0) 4.10  








𝑃(𝑡) = 𝑄𝑃(𝑡) 4.12  
An expression for 𝑃(𝑡) can therefore be written as: 
 𝑃(𝑡) = 	 𝑒JM 4.13  
Where 𝑄 is referred to as the generator matrix, which satisfies the conditions: 
 𝑄"+ ≥ 0	∀	𝑖 ≠ 𝑗 4.14  
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 G𝑄"+ = 0
+
 4.15  
The results from Equations 4.10 and 4.13 can be used to describe the time evolution of the Markov 
system:  
 𝑀(𝑡 + 𝑛) = 𝑒M(J(/)𝑀(t) 4.16  
 
4.1.5 Deep Learning and Recursive Neural Networks 
Deep learning refers to a broad class of machine learning methods which are capable of learning 
latent/higher order characteristics of a dataset in order to achieve a user-defined goal (typically the 
minimization of an objective function). While there are no structural requirements for deep 
learning algorithms, the most widely successful implementations of deep learning have been 
realized through artificial neural networks (ANNs). Inspired by and named after biological neural 
networks, ANNs consist of layers of nodes, with each node receiving input through weighted 
connections to other nodes and producing an output determined by a non-linear activation function. 
During training, a neural network learns to optimize the weights of the connections between nodes 
through a process called backpropagation, in which parameters are iteratively updated by 
calculating the gradient of the loss function with respect to each weight in the network.24 ANN-
based deep learning algorithms have enjoyed widespread success across a diverse range of 
applications in medicine and hold the potential to revolutionize the field of radiation oncology.25 
Recursive neural networks (RNNs) are neural networks which can handle sequence data.26 
RNNs differ from traditional ANNs in that all of the nodes in an RNN share the same weights and 
biases. In addition, because they take an entire sequence as input, the width of an RNN (number 
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of nodes per layer) is usually set as the number of events (or timesteps) per sequence. Each node 
in an RNN takes two categories of information as input: information about the current state of the 
sequence (either from the input data or from the output of the node in the previous layer) and 
information about the previous states, represented by a hidden state, ℎ8"). The flow of information 
in an RNN can thus be thought of as traveling both across the sequence and upwards through the 
layers.  
4.1.6 Study Objectives  
In this study, we present a novel method of predicting patient changes over the course of treatment 
which models the patient as a stationary quantum state whose timepoints are discretized by fraction 
number. The motivation for modeling the dynamics of patient anatomy as a quantum system is 
informed by the nature of quantum systems. Specifically, it is impossible for human observers to 
predict the behavior of a quantum system with absolute certainty. Similarly, in a radiation 
oncology paradigm, the aforementioned limitations in CBCT image quality in combination with 
daily setup variations, physiological changes such as tumor response, and anatomical motion, 
mean that there are inherent uncertainties in knowing a patient’s “state” during the course of 
treatment. The non-deterministic nature of these two systems lends to the notion that modeling 
patient changes after the evolution of a quantum system may lead to more accurate predictions 
than those which could be achieved using a classical predictive framework. 
To test this hypothesis, we designed a predictive framework which models patient changes 
as a stationary quantum system defined by the time-independent Schrodinger equation evolving 
according to a patient-specific Hamiltonian. The parameters of the Hamiltonian are derived from 
an RNN, which takes data from the first several fractions of a patient as input in order to predict 
later fractions. In addition, we also developed a Markov-based predictive framework which models 
 95 
patient changes according to the Kolmogorov backward equation and a patient-specific generator 
matrix. We trained and evaluated both frameworks on a head and neck cancer (HNC) radiotherapy 
dataset, which was selected because HNCs represent a patient population which commonly 
experiences geometric changes leading to plan adaptations.7 
4.2 Methods 
4.2.1 Patient Population and Data Acquisition 
Training data for this study were acquired retrospectively from a dataset of 128 HNC patients who 
received VMAT at one institution between the years of 2013 and 2016. Of the original 128, three 
patients were excluded due to abnormalities which occurred during their treatment sequence. The 
remaining 125 patients consisted of 102 (23) males (females) with an average age of 58.3 (range 
= [10, 84]). (Note that this gender imbalance is typical for HNC populations.27) Patients received 
a target prescription dose between 60-70 Gy delivered over 30-35 fractions, with as many as 17 
patients undergoing replanning. Oropharyngeal cancers which are positive for human papilloma 
virus (HPV) have been shown to have higher radiosensitivity.28,29 Of the patients whose tumor site 
was located in the oropharynx (n=68), 52 were recorded as positive for human papilloma virus 
(HPV), 5 were negative, and 1 was unknown. Patient immobilization of the upper body was 
achieved using 5 point masks and daily setup errors were corrected using CBCT image guidance. 
An additional 20 HNC patients treated with 30-35 fractions of VMAT radiotherapy 
between 2018-2020 were selected to serve as an external testing dataset. The patients consisted of 
14 (7) males (females) with an average age of 60 (range = [22, 86]). Deformable image registration 
was performed on daily CBCT images for two fractions per treatment week, and volume/table 
shifts were calculated from these fractions in the same manner as the training dataset.  
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4.2.2 Data Preprocessing  
The data used to define the patient state at each treatment fraction consisted of fractional primary 
clinical target volumes (CTVs) (with respect to the volume at the first fraction) as well as daily 
table shifts (lateral, longitudinal, vertical) used for patient alignment (Figure 4.1). Patient rotation 
angles (defined as the yaw angle of the treatment couch) were initially recorded but were ultimately 
omitted from the model because the majority of patients did not undergo rotational shifts during 
treatment. Pitch and roll angles were also omitted because all of the patients in the training dataset 
were treated on 4D couches (which perform translations and rotations around the yaw axis). 
Deformable image registration (DIR) was performed by an experienced dosimetrist 
between daily CBCT images, and the planning CT as described previously.13 The majority of 
patients utilized CBCTs from every treatment fraction, while the rest included at least two fractions 
per treatment week. CTV volumes were then obtained from the daily CBCT images and 
normalized with respect to the volume of the first fraction in their respective treatment course. The 
motivation for reporting fractional (or relative) volumes as opposed to raw volumes was in part 
due to the wide range of volume sizes across patients [2.5cc - 456cc] and the need to relate 
meaningful tumor volume changes between patients (i.e., depending on tumor size, a 2cc reduction 
in tumor volume could represent an 80% reduction in tumor volume in one patient and only a 0.5% 
reduction in another). Daily table shifts and rotations were calculated as the difference between 
table coordinates recorded for the daily CBCT image and the DICOM treatment record 
(RTRECORD).  
Fractions within a treatment sequence were also omitted from the model if they did not 
meet the inclusion criteria described below. The recorded CTV volumes and table shifts 
occasionally contained anomalies which did not represent meaningful changes across the treatment 
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fractions. For example, some CTV volumes were measured which appeared as large spikes in the 
overall fraction sequence. Upon inspection of the original CBCT structure sets in Aria (Varian), it 
was found that these spikes in volume could be attributed to an error in the deformable image 
registration. To resolve this issue, fractions were discarded whose volume differed from both the 
fraction immediately prior and immediately preceding by > 10 cc. Abnormal table shifts were 
defined as a shift which exceeded 15 mm in any direction. These instances were attributed to large 
setup deviations from the original planning CT. Fractions with shifts exceeding this cut-off were 
excluded when they occurred sparsely throughout a treatment regimen. In two patients, CBCT 
shifts were recorded which exceeded 40 mm for every fraction. Because these represented a 
consistent setup variation from the planning CT, the shifts in these fractions were not discarded 
and were instead normalized by subtracting off the shift in the first fraction to more faithfully 
represent position modifications that were not due to setup error. This ultimately resulted in the 
exclusion of 99 fractions across 35 patients for volume spikes and 8 fractions across 7 patients for 
table shift abnormalities (out of 3657 total fractions). Data preprocessing was performed in the 
same manner for the external testing dataset, with a total of 7 fractions from this dataset discarded 
(from a total of 678 fractions) for failing to meet the inclusion criteria defined above. 
After cleaning, the dataset underwent data augmentation, in which missing fractions were 
filled in by their nearest neighbor. Even fractions were discarded such that the final dataset used 




Figure 4.1: Schematic of data collected from each patient across treatment fractions. Primary CTV volumes 
were acquired from daily CBCTs and daily table shifts (described by the coordinate space shown in the 
treatment system) were collected for each available fraction and used to define an orthonormal state vector. 




4.2.3 Mapping to Discrete Orthonormal State Vectors 
In order to model patient anatomical changes as a quantum system, the patient characteristics 
(volume + table shift values) at each point in time (fraction #) were mapped to an orthonormal 
state vector, Ψ' ,	where Ψ'∈[),P] form a basis in an N-dimensional Hilbert space, and 𝑁 is the number 
of potential states the patient can be in at a given time. It is desirable to select a value for N so as 
to balance the need to ensure that the Hilbert space contains enough dimensions to meaningfully 
capture the complexity of the patient population but is not so large as to result in large numbers of 
sparsely used discrete states. The dataset was encoded using several different values of N to assess 
the predive models’ performance under this tradeoff. 
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The primary CTV volumes and daily table shifts were converted to orthonormal state 
vectors by first mapping them to discrete state values using vector quantization.30 A generalization 
of Lloyd-Max scalar quantization, vector quantization is a data reduction technique which finds 
an optimal codebook of vectors such that for a given dataset, the total difference between each 
multivariate sample and its nearest codebook neighbor is minimal. Once the codebook has been 
calculated, each sample vector mapped to its nearest codebook neighbor, and the dimensionality 
of the data is effectively reduced to the number of vectors (or states) contained within the 
codebook. Vector quantization was performed via the Vector Quantization Design Tool (vqdtool) 
available through MATLAB’s DSP system toolbox (Mathworks, Inc.), after which each state was 
encoded as a one-hot vector. Figure 4.2 displays an example of the distribution of lateral shifts 
recorded across all fractions from the original dataset (a) and after encoding to 4 states (b) and 10 
states (c) as well as a subset of the lateral shifts recorded from the original dataset (orange) and 
after encoding (blue) (e & f). It is clear that the 10-state encoding, while computationally more 
expensive, provides a closer approximation to the original data. The external testing dataset was 
quantized using the same codebook as the training data. Note that the 10-state encoding only 
includes 6 discrete states for the lateral shifts (Figure 4.2(c)). This is because the vector quantizer 
looks for the optimal representation of the distribution of vectors within a multidimensional 





Figure 4.2: Distribution of lateral shifts recorded across all fractions from the original dataset and after 
encoding to 4 and 10 states, as well as a subset of the lateral shifts recorded from the raw, unquantized 
dataset (orange) and after encoding (blue). 
 
4.2.4 Generation of Additional Synthetic Data via Generative Adversarial Network (GAN) 
One challenge for this study was the limited number of patients available to train the proposed 
models. To address this challenge, a Time-series generative adversarial network (TimeGAN) was 
employed to generate additional synthetic data.31 Generative adversarial networks describe a class 
of deep learning algorithms which learn the latent distributions of a dataset by pitting two 
competing networks against each other. The generator network seeks to generate realistic “fake” 
data samples to fool a discriminator network, which seeks to distinguish real samples from fakes. 







which a well-trained discriminator identifies correctly only 50% of the time. TimeGAN learns the 
distributions of features across time by utilizing RNNs for both the generator and the discriminator 
as well as introducing a supervised loss term in addition to the traditional unsupervised adversarial 
loss. Finally, TimeGAN also utilizes an additional embedding network which learns a reversible 
mapping between latent space and features. Our implementation of TimeGAN followed the same 
architecture and hyperparameters as the original publication.31 Synthetic data was generated in the 
form of discrete state values produced from vector quantization (i.e., after discrete state mapping 
but prior to one-hot encoding). In order to prevent model leakage, TimeGAN was trained on five 
separate training folds used to train outer loop of the predictive models during nested cross 
validation. This resulted in an additional 200 samples per fold, for a total of 325 patients for model 
evaluation.  
In order to assess the quality of the synthetic data, histograms counting all instances of each 
discrete state across all fractions and patients were calculated, and t-distributed stochastic neighbor 
embedding (t-SNE) as well as principal component analysis (PCA) analyses were performed 
(flattened in the time dimension) to visually compare the original and synthetic data. In addition, 
two quantitative performance scores, a discriminative score and a predictive score, were obtained 
by training two separate neural networks. The discriminative score was calculated by training a 
discriminator (in the form of an RNN) to classify real vs. synthetic samples, and then reporting the 
classification error from a holdout testing dataset. The predictive score was calculated by training 
an RNN network using the synthetic dataset to predict the state in the next time step, and then 
reporting the mean absolute error of the model when tested on the original data. Figure 4.3 displays 
the results of the data visualizations (a, b, d, & e) as well as the testing scores for the discriminator 
and predictive networks (c), which are compared against the results of the model trained on another 
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sequence-based, medical dataset consisting of a private lung-cancer pathways dataset as reported 
in Yoon et al, 2019.31 
 
 
Figure 4.3: Assessment of synthetic data generated by TimeGAN for the 10-state vector encoding trained 
using original data from fold 5: (a) shows the distribution of the original 10-state encoded data, (b) shows 
the distribution of the synthetic, (c) displays discriminative and predictive scores for the HN synthetic data 
(H&N) and the scores from the lung cancer pathways data (Lung*) reported in the original TimeGAN 
paper, (d) and (e) display t-SNE and PCA plots respectively for the original 10-state data and the synthetic 
10-state data.   
 
4.2.5 Quantum-based Prediction Algorithm 
After mapping patient attributes to state vectors, the remaining key piece of information necessary 
to predict future patient states is to acquire an expression for the Hamiltonian, which determines 






was derived from the output of a gated recurrent unit (GRU) neural network,32 which we refer to 
as the QRNN. In order to preserve the unity length of predicted states as well as ensure that the 
squared probability amplitudes sum to 1, the predicted Hamiltonian must be Hermitian (i.e., equal 
to its conjugate transpose). However, because PyTorch is currently limited in its use of complex 
numbers within ANNs, we assumed a real-valued Hamiltonian and therefore needed only to build 
a symmetric matrix from the GRU output. State vectors from the several fractions are used as input 
to the GRU, and the network outputs parameters necessary to construct the Hamiltonian in the 
form of vector of length (𝑁 + 1) × 𝑁/2, where 𝑁 is the total possible number of states. This 
parameter vector was then used to construct a symmetric (and by default Hermitian) matrix 
according to Section 1.2.7 in Golub and Van Loan, 2013.33 In order to calculate the unitary 
transition matrix defined by Equation 4.5, the expression for the transition matrix was reformulated 
using Euler’s formula and spectral decomposition was used to perform the necessary operations 
on the Hamiltonian matrix: 
 𝑒6"KJ = cos(𝐻𝑡) − 𝑖𝑠𝑖𝑛(𝐻𝑡) 4.17  
 
 𝑓(𝐻) = 	𝑣N𝑓(𝜆)𝑣 4.18  
Where 𝑣 and 𝜆 are the respective eigenvectors and eigenvalues of 𝐻. The transition matrix was 
split into its real and complex components such that: 
 «𝑅𝑒
(𝑈) = 	𝑣N cos(𝜆𝑡) 𝑣
𝐼𝑚(𝑈) = 	𝑣N sin(𝜆𝑡) 𝑣
 4.19  
Where 𝑡 is expressed as an integer and determines which future fraction to be predicted. (Note that 
we can parameterize 𝑡, as 𝑡 = 2𝑥 such that |𝛹(𝑡& + 𝑡)⟩ = |𝛹(𝑡& + 2𝑥)⟩ to yield odd numbered 
fractions.) Future fraction predictions,|𝛹m(𝑡& + 𝑡)f were acquired by calculating the probability 
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amplitude of each state after applying the unitary transition matrix to the known system state of 
fraction 𝑡&: 
 |𝛹­(𝑡* + 𝑡)¢ = 	𝑈(𝑡)|𝛹(𝑡*)⟩ 4.20  
 
 =	𝑣N cos(𝜆𝑡) 𝑣|𝛹(𝑡*)⟩ − 𝑖𝑣N sin(𝜆𝑡) 𝑣|𝛹(𝑡*)⟩ 4.21  
 
 𝑃®|𝛹­(𝑡* + 𝑡)¢ = |𝑣"∈{$,/}¢¯ = 𝑎"- 4.22  
Where 𝑎', is the ith element in the vector given by: 
 𝑎- =	®|𝛹­(𝑡* + 𝑡)¢¯
.- 4.23  
 
 = ®𝑅𝑒(|𝛹(𝑡* + 𝑡)⟩)¯
.- + ®𝐼𝑚(|𝛹(𝑡* + 𝑡)⟩)¯
.- 4.24  
Where “. 2” refers to element-wise multiplication. The predicted future state was then defined as 
the basis vector with the largest probability. The model loss function was then defined as the 
negative log likelihood of the algorithm predicting the correct future state: 
 𝑄𝐿𝑜𝑠𝑠 = log(|Ψ(𝑡)⟩|-) − log(|𝑈(𝑡)|Ψ(𝑡*)⟩|-) 4.25  




Figure 4.4: Schematic of QRNN Algorithm. A set number of initial states are fed into a recurrent neural 
network, which produces a vector of parameters necessary to build a Hamiltonian matrix. The Hamiltonian 
is then used to construct a transition matrix, which in turn is used in conjunction with the oldest initial state 
to predict the probability of each remaining fraction existing in a given state. The fraction state predictions 
are then used in conjunction with the ground truth to calculate the model loss. 
 
4.2.6 Markov-based Prediction Algorithm (MRNN) 
Similar to the quantum model, the Markov model also utilized a GRU neural network (which we 
refer to as the MRNN) and took the first 13 odd fractions as its input. The output of the MRNN 
was a vector of length 𝑙 = 𝑁 × (𝑁 − 1), where again 𝑁 is the total number of possible states. A 
generator matrix, 𝑄, was then built from this parameter vector such that Equations 4.14 and 4.15 
were satisfied. The probability transition matrix defined by Equation 4.13 was then calculated.34 
The probability distribution of future states was thus calculated as: 
⟩|#(%) |# ⟩(') ⟩|#(%')⟩|#(() ⟩|#())
RNN
!
RNN outputs vector of length necessary to 
completely define Hamiltonian 
Hamiltonian matrix is used to construct
Unitary transition operator. Predictions are 
calculated for future states
*| +#(%() | +# ⟩(%)) *| +#('()*| +#(%,) *| +#(21)
⟩|#('()
First 13 fractions are fed as input to a 
Gated Recurrent Unit (GRU) RNN
⟩|#(/)*| +#(/) Loss function calculated as Negative Log Likelihood NLL
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 𝑀(𝑡* + 𝑡) = 𝑒MJ𝑀(𝑡*) 4.26  
And the predicted future state was assigned as the state with the maximum probability. The loss 
function for the MRNN was then defined as the negative log likelihood between the Markov-
predicted state and the known future state: 
 𝑀𝐿𝑜𝑠𝑠 = log®𝑀(𝑡*)¯ − log(𝑒MJ𝑀(𝑡*)) 4.27  
4.2.7 Model Architecture and Training 
The models were built and trained with Python using the PyTorch library on a Windows 10 desktop 
computer (AMD Ryzen 5 3600 6-Core Processor, 3.59 GHz, NVIDIA GeForce GTX 1660 
SUPER). The neural networks for both models utilized Adam optimization with a learning rate of 
0.001 and a batch size of 30. The QRNN and MRNN models were trained and assessed using a 
nested cross validation (NCV) scheme to mitigate overfitting effects and assess generalizability.35 
NCV involves performing an inner loop of cross validation (CV) on each training fold for 
parameter tuning in order to avoid introducing additional bias into the model assessment. The inner 
loop consisted of 5-fold CV and was trained for 50 epochs in order to train the number of layers 
in the GRU as well as the dropout values. Optimal parameters were based on the minimum loss 
model loss achieved over every combination of parameter values. The outer loop consisted of 5-
fold CV and was trained for 100 epochs, which was determined experimentally. Model loss, area 
under the receiver operating characteristic curve (AUC), and confusion matrices were recorded to 
assess model performance.  
4.3 Results 
For each system state representation 𝑁 ∈ {4, 6, 8, 10}, models were trained using the first 13 odd 
fractions as input to predict the remaining odd fractions (15-35). To assess model performance, 
AUC scores were calculated for each model using the scikit-learn library’s roc_auc_score() 
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function with parameters set such that the metrics for each label were weighted by the number of 
true instances for each label, and the AUC reported was the average AUC of all possible pairwise 
combinations of classes.36 AUC scores were computed both across all fractions (15-35) and on a 
per fraction basis in order to assess both general model performance as well as model performance 
at specific timepoints.  
4.3.1 Overall Results 
Table 4.1 displays the validation AUC scores calculated using all future fractions (15-35) averaged 
over the 5 folds of cross validation (outer fold of nested CV) as well as z-scores and corresponding 
p-values calculated from the DeLong test for each system state representation.37 From the results 
in Table 4.1, the MRNN model was observed to have a generally higher performance on the 
validation set than the QRNN model; however, these differences were only statistically significant 
(𝑝 < 0.05) for the 8-state and 10-state representations. In addition, both models seemed to 
experience reduced performance with increasing state-vector size (with the exception of the 8-state 
MRNN results). 
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Table 4.1: Validation AUCs averaged over 5-folds of cross validation recorded for MRNN and QRNN 
models after 100 epochs. (mean ± 95% confidence interval [CI]), as well as z-scores and corresponding p-
values from the DeLong test. 
Validation AUC after 100 Epochs 
State-vector size MRNN  QRNN Z-score p-value 
4	 0.742	±	0.021	 0.675	±	0.036	 1.35	 0.177	
6	 0.709	±	0.026	 0.656	±	0.021	 1.83	 0.068	
8	 0.724	±	0.036	 0.652	±	0.044	 2.53	 0.011	
10	 0.698	±	0.016	 0.605	±	0.035	 2.67	 0.007	
 
Figure 4.5 displays the AUC scores on the internal validation dataset of the outer loop of 
NCV validation after 100 epochs of training. The results in Figure 4.5 suggest that for both the 
MRNN and QRNN models, the AUC score appears to decrease for increasing system state sizes. 
In addition, there also appears to be a slight decrease in AUC score for fractions at later timepoints. 
One challenge of calculating AUC scores on a per-fraction basis is that this leads to fewer 
samples used to determine each score. In order to calculate the AUC, it is necessary for sample set 
to contain instances (true labels) of every possible class. Because of this requirement and the fact 
that it is not possible to stratify patients across folds such that each fraction has an equal 
distribution of state values, it is possible for some folds to have undefined AUC values at specific 
fractions. For such instances, the mean AUC values and CIs were reported based on the remaining 
folds. This resulted in models sometimes artificially appearing to have smaller measurement 
uncertainties—for example, the MRNN and QRNN models trained using system state vectors of 
size 10 had 4 out of 5 folds which contained undefined AUC scores at fraction 25. Table 4.2 
summarizes the number of folds left out for each fraction during the per-fraction AUC calculations. 
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The higher order system state representations (8 and 10) were found to suffer from a higher number 
of undefined folds. 
 
Figure 4.5: MRNN and QRNN validation AUC scores vs fraction number for each system state 
representation. Shaded region indicates the 95% confidence interval. 
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Table 4.2: Number of folds omitted from each fraction during AUC score calculation due to lack of 
samples for each possible class. 
 
Number of folds omitted from AUC calculation 
Fraction # 4-state 6-state 8-state 10-state 
15	 0	 1	 2	 2	
17	 0	 1	 1	 1	
19	 0	 1	 2	 3	
21	 0	 1	 3	 3	
23	 0	 1	 2	 3	
25	 0	 0	 1	 4	
27	 0	 0	 2	 1	
29	 0	 0	 1	 2	
31	 0	 0	 1	 1	
33	 0	 1	 0	 3	
35	 0	 0	 3	 2	
 
4.3.2 4-state Predictions 
Figure 4.6 displays the results for the 4-state quantum and Markov models, including the mean 
training and testing AUCs recorded over 100 epochs during the outer loop of 5-fold cross 
validation (a & b), the corresponding model loss (c & d), as well as confusion matrix metrics: 
sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) 





Figure 4.6: QRNN and MRNN model results for 4-state system predicting fractions 15-35: AUC scores 
(mean and 95% CI) (a) & (b), model loss (c) & (d), and confusion matrix metrics: sensitivity, specificity, 
positive predictive value (PPV), and negative predictive value (NPV) averaged across 5-folds after 100 






4.3.3 6-state Predictions  
Figure 4.7 displays the results for the 6-state quantum and Markov models, including the mean 
training and testing AUCs recorded over 100 epochs during the outer loop of 5-fold cross 
validation (a & b), the corresponding model loss (c & d), as well as confusion matrix metrics: 




Figure 4.7: QRNN and MRNN model results for 6-state system predicting fractions 15-35: AUC scores 
(mean and 95% CI) (a) & (b), model loss (c) & (d), and confusion matrix metrics: sensitivity, specificity, 
positive predictive value (PPV), and negative predictive value (NPV) averaged across 5-folds after 100 






4.3.4 8-state Predictions 
Figure 4.8 displays the results for the 8-state quantum and Markov models, including the mean 
training and testing AUCs recorded over 100 epochs during the outer loop of 5-fold cross 
validation (a & b), the corresponding model loss (c & d), as well as confusion matrix metrics: 





Figure 4.8: QRNN and MRNN model results for 8-state system predicting fractions 15-35: AUC scores 
(mean and 95% CI) (a) & (b), model loss (c) & (d), and confusion matrix metrics: sensitivity, specificity, 
positive predictive value (PPV), and negative predictive value (NPV) averaged across 5-folds after 100 






4.3.5 10-state Predictions 
Figure 4.9 displays the results for the 10-state quantum and Markov models, including the mean 
training and testing AUCs recorded over 100 epochs during the outer loop of 5-fold cross 
validation (a & b), the corresponding model loss (c & d), as well as confusion matrix metrics: 






Figure 4.9: QRNN and MRNN model results for 10-state system predicting fractions 15-35: AUC scores 
(mean and 95% CI) (a) & (b), model loss (c) & (d), and confusion matrix metrics: sensitivity, specificity, 
positive predictive value (PPV), and negative predictive value (NPV) fractions averaged across 5-folds after 






4.3.6 External Testing Results 
Final models for each system-state representation were trained using all of the real training data 
(N = 125) as well as 250 synthetic samples (50 samples randomly selected from each of the 5 outer 
cross validation folds) so that the ratio of real to synthetic training data was the same as used during 
the cross validation process (1:2). For comparison, an additional set of final models were also 
trained using only real data. The hyperparameters for each model were selected as those chosen 
most frequently during nested cross validation. All models had an RNN depth of 2 layers and 
dropout coefficients, which ranged from 0.1-0.5. Model testing was performed using the external 
dataset of 20 patients described in Section 4.2.1. Table 4.3 displays the final testing AUC scores 
for each model; these are consistent with the training cross-validation results, where the MRNN 
approach was found to achieve higher AUC scores than the QRNN, though model performance 
was relatively less sensitive to the order of the system state representation. 
 
Table 4.3: Testing AUC scores calculated as the highest achieved over the course of 100 epochs of training. 
Results include models trained with real and synthetic data as well as models trained without synthetic data 
(labeled as “no GAN”). 
Testing AUC  
State-vector size MRNN  QRNN MRNN (no GAN) QRNN (no GAN) 
4	 0.729	 0.650	 0.707 0.623 
6	 0.677	 0.651	 0.687 0.608 
8	 0.716	 0.683	 0.723 0.669 




In this work we presented two approaches for radiotherapy geometric adaptation based on quantum 
computing and Markov methods within a deep learning framework. Overall, the Markov predictive 
model was found to exhibit slightly higher performance (though not always statistically 
significant) than the quantum predictive model—both across all fractions (Table 4.1) and on a per-
fraction basis (Figure 4.5). One possible explanation for this outcome is the difference in the 
number of parameters necessary to construct the quantum-based Hamiltonian and the Markov 
generator matrix. The Markov generator matrix is required to have positive off-diagonal values 
and rows which sum to 0, requiring 𝑁 × (𝑁 − 1) parameters for 𝑁 states. The Hamilton matrix is 
required to be Hermitian (in this case symmetric due to the additional assumption that it contained 
only real values), requiring 𝑁/2 × (𝑁 + 1) parameters for 𝑁 states. This resulted in the Markov 
model having two additional learned parameters for the 4-state representation and 35 additional 
parameters for the 10-state. In future studies, (once complex numbers are supported by the 
autograd function in Pytorch) we plan to reformulate the QRNN model such that the Hamiltonian 
can more realistically contain any value in the complex plane. This would represent an increase in 
the degrees of freedom for the QRNN model and could help to better improve its performance 
compared to the MRNN model. 
 For external testing, final MRNN and QRNN models were trained in one of two ways – 
either with both real and synthetic data, or with only real data. For the MRNN testing results, it 
was found that the models trained using only real data outperformed those with synthetic data for 
three of the four system state vectors, while the opposite trend was observed in the QRNN model 
results. However, if we estimate that the uncertainty associated with the testing results is at least 
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as large as the 95% confidence intervals reported for the cross validation then these trends do not 
appear to be significant. 
A key challenge for the MRNN and QRNN predictive models is to determine an adequate 
size of the system state vector. Higher dimensional vectors are preferable from a clinical standpoint 
because they can more faithfully represent the original data as demonstrated by Figure 4.2 (d) and 
(e). In addition, higher dimensional system state vectors can more easily allow for the 
incorporation of additional types of patient data—such as biomarkers, radiomics, or dosimetric 
information—allowing for a more complete and individualized representation of patients. 
However, the results of this study suggest that there is a tradeoff between model performance and 
state vector complexity. This observation is not surprising: because the problem is formulated as 
a multi-class classification problem, an increase in system-state vector size increases the number 
of classes which the model must learn to distinguish without increasing the number of samples—
effectively forcing each class to be more sparsely represented. This challenge makes it particularly 
difficult to draw confident conclusions about both models’ predictive abilities across different 
fractions (Figure 4.5). Based on the 4-state and 6-state results it appears there may be a slight 
reduction in model performance as the fraction number to be predicted grows further from the last 
initial state. However, the sparsity of representation across the possible states meant that the higher 
order representations (8-state and 10-state) had many fractions in which folds were omitted due to 
an inability to calculate the AUC using the samples. Finally, it is worth noting that of all of the 
system state vector lengths investigated in this study, only the 4-state models continued to learn 
over the entire course of 100 epochs (Figure 4.6). The other three higher order models all reached 
their maximum performance within the first 20-50 epochs and began overfitting from that point 
afterwards.  
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The current workflow for implementing plan adaptations on HNC patients involves 
identification of anatomical changes through visual inspection of daily CBCT images. When 
dramatic changes are identified by the clinical team, a new CT simulation can be performed to 
better quantify those changes and to assist in adaptive replanning. This current ART workflow is 
hindered by the time constraints inherent in a clinical environment. Models which can predict 
patient changes during treatment could help to alleviate this challenge by allowing clinical teams 
to anticipate and prepare for adaptions before they are necessary. Several previous studies have 
reported on the use of predictive models for HN cancer. Rosen et al. reported a model which 
predicted radiation-induced xerostomia using dose volume histogram metrics along with CBCT 
image information from the last two weeks of treatment 13. In another study, McCulloch et al. 
reported a model which predicted the need for replan based on estimated dose deviations calculated 
using daily CBCT images from the 5th, 10th, and 15th fractions 12. To our knowledge, the models 
presented in this study are the first which predict anatomical changes beyond the next treatment 
fraction using early treatment data (the first 13 fractions). This approach allows for predictions to 
be made far enough in advance for clinical intervention and could also be used to improve future 
prediction studies. For  example, geometric predictions could be coupled with daily dose 
calculations to provide a more accurate estimation of dosimetric deviations. These models further 
distinguish themselves from previous studies in that they can be formulated to encode any aspect 
of the patient state (geometrical, physiological, dosimetric, or higher order latent features). 
The most accurate data driven models for outcome prediction are deep learning models 
because they can recognize complex nonlinear relationships in data. However, machine learning 
is sensitive to noise in the data, and in our case because there are inherent uncertainties in knowing 
the state of the patient during any given fraction, we can only offer noisy data to the algorithm for 
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training. The motivation for utilizing Markov/quantum models is that both of rely on probabilistic 
transition matrices to predict changes over time and are formulated deal with systems that have a 
stochastic component/inherent uncertainties.   
The limitations associated with this study are summarized as follows: the patient variations 
predicted in this study were limited to geometric anatomical changes over the course of treatment. 
While there is limited consensus on which exact patient changes are relevant and/or necessary to 
track for the purpose of ART, dosimetric information (in particular dose deviations from the 
original treatment plan) represents another category of data commonly used for informing ART 
decisions. In addition, because many HNC patients experience xerostomia induced by radiation 
toxicity, it would be valuable to also include data related to the parotid glands in future studies. 
Due to a number of factors, including the CTV structure boundaries ending outside the field of 
view of the daily CBCTs as well as occasional failure of the DIR algorithm, it was not possible to 
include every treatment fraction for each patient. While generally at least 2 fractions per week 
were included, the RNN models might be more successful at learning relevant time-dependent 
patterns in the patient data if all fractions could be included. Finally, this study did not consider 
the impact of “measurements” on the patient system. In a quantum framework, any measurement 
on the system changes the state of the system itself (often referred to as “collapsing the systems 
wave function”). While the values predicted in this study were treated as somewhat artificial 
measurements (primarily because the quantitative value of the day-to-day volume of the primary 
CTV and treatment couch position, while potentially valuable, are not currently explicitly used in 
the clinical workflow for ART decision-making), it would be interesting in future studies to 
consider how these models can predict the impact of clinical decisions (such as the choice to 
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modify a plan) over the course of treatment. Such a study may reveal additional benefits that are 
more unique to the quantum-based QRNN model. 
4.5 Conclusion 
In this study we report on the design and assessment of two novel deep machine learning 
frameworks for predicting anatomical changes in radiotherapy patients. A comparison between the 
performance of the quantum-inspired and Markov-inspired models indicated that the Markov 
models tend to exhibit higher performance. In addition, it was found that there was a tradeoff 
between model performance and the size of the system state vector. A major challenge of this 
study was that as the system state dimension increased, so did the sparsity of class representation, 
leading to a decrease in model performance. Further studies utilizing both greater numbers of 
patients with diverse treatment outcomes, information regarding clinical decisions over the course 
of treatment, as well as additional datatypes beyond basic imaging features such as tumor volume 
are necessary to fully evaluate the predictive power of these models. 
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Chapter 5 Prediction of Adaptation Decisions and Outcomes in Larynx Cancer Patients 
 
This chapter features two related studies conducted through collaboration with physicians at 
Michigan Medicine. The candidate’s role in these studies involved processing image data and 
calculation of radiomic/imaging features, as well as training, validation, and testing of the classical 
and deep learning models. The physicians’ role included contouring of computed tomography (CT) 
images, acquisition of relevant clinical features/outcomes from patient charts, and providing 
clinical expertise in interpretation of results. Results from the first study are currently undergoing 
peer review in: 
 
Gharzai, L. A., Pakela, J. M, Jaworski, E., El-Naqa, I., Schonewolf, C. A., Hawkins, P. G., Wilkie, 
J. R., Spector, M. E., Bradford, C. R., Chinn, S. B., Hogikyan, N., Malloy, K., Kupfer, R., Shuman, 
A., Stucken, C. L., Prince, M., Shah, J., Swiecicki, P. L., Casper, K., Eisbruch, A., Wolf, G., 
Worden, F., Srinivasan, A., Mierzwa, M. L. (expected 2021), Imaging response versus operative 
laryngoscopy assessment of induction chemotherapy response in an induction bioselection 
approach to larynx cancer. (submitted to Oral Oncology).  
 
Another manuscript is under processing with a focus on deep learning application that the 




5.1.1 Bioselection as a Method for Adaption in Larynx Cancer Patients 
In larynx cancer, the use of bioselection treatment strategies based on tumor response to induction 
chemotherapy (IC) has been tied to improved patient outcomes—including overall survival (OS) 
and larynx preservation.1,2 The current bioselection paradigm involves patients undergoing direct 
laryngoscopy after their first round of chemotherapy (i.e., IC) in order to assess their tumor’s 
response to the treatment. During the laryngoscopy, a surgeon visually inspects the primary tumor 
and provides a clinical assessment of its response. Patients who experience ≥ 50% tumor response 
(according to surgical assessment) advance to chemoradiation; otherwise, patients undergo a 
laryngectomy—a surgical removal of the larynx which critically alters or impairs a patient’s ability 
to speak, taste, smell, and swallow.3,4 The use of a bioselection approach is therefore valuable not 
only for its improvement in patient survival rates but also in its ability to preserve patient quality 
of life. Despite data in support of this approach, barriers exist related to the direct laryngoscopy 
procedure (including financial cost, patient risks from intubation/anesthetization, and surgeon 
availably) which limit its wider implementation. In addition, because this assessment is made via 
physical observation by a surgeon, it is largely subjective and may suffer from limitations in 
accuracy and intra-observer variability.  
5.1.2 Data-driven Outcomes Prediction in Head and Neck Cancers 
Data-driven outcomes prediction is an active field in radiation oncology that plays a role in helping 
clinicians better understand the relationship between patient features and clinical outcomes, 
allowing for implementation of personalized medicine—in which a patient’s unique characteristics 
and biomarkers play a role in identifying their optimal treatment. In head and neck cancer, there 
exists a substantial number of studies evaluating the use of many different types of clinical features 
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as prognostic factors for patient outcomes.5-10 For larynx cancer in particular, the incorporation of 
data extracted from radiological medical images (radiomics) has been recognized to be of potential 
value for better understanding and management of a cancer characterized by complex regional and 
functional anatomy.11 There has also been increasing interest in the use of advanced machine 
learning methods such as deep learning (DL) models for  outcomes prediction, particularly for the 
incorporation of higher dimensional feature sets, including radiomics and genomics, and for the 
ability to engineer features directly from medical images.12,13 
5.1.3 Study Objectives 
In the case of laryngeal cancer patients, a better understanding of the relationship between 
quantitative patient features and clinical outcomes could help to make the bioselection process less 
subjective. Additionally, a fully verified model could potentially serve in place of, or in supplement 
to, a surgeon’s expert assessment: particularly in non-academic centers with greater resource 
constraints. To this end, the primary goal of this study was to retrospectively investigate the use 
of quantitative, non-invasive features in the form of imaging radiomics, lab, and clinical data as 
predictors for two types of outcomes: overall survival (OS) and laryngectomy free survival (LFS) 
for patients undergoing bioselection treatment. We also investigated the use of these quantitative 
features to predict the surgeon-assessed response to IC (ICR). The secondary goal of this study 
was to investigate whether a particular class of data-driven model (traditional linear models or DL) 
was better suited for this task.  
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5.2 Methods 
5.2.1 Patient Cohort 
The inclusion criteria for this study consisted of locally advanced laryngeal cancer patients who 
were treated with a bioselection paradigm and had contrast-enhanced CT images taken 
immediately prior to and after induction chemotherapy as well as valuable laboratory data. The 
training dataset for this study consisted of 93 patients who were treated at a single institution and 
belonged to one of two prospective clinical trials (UMCC 9520 and NCT 01633541). An additional 
22 laryngeal cancer patients who also underwent bioselection off-trial were selected as an external 
testing dataset. The demographics and treatment information of both datasets are summarized in 
Table 5.1. 
 
Table 5.1: Demographics of the training and testing dataset. 
Patient Demographics 
 Training Dataset  
(n=93) 
Testing Dataset  
(n=22) 
 N (%) N (%) 
Clinical Information   
Age (years, median, range) 57 (19-82) 58.5 (29-77) 
Pre-treatment tumor size (cc, mean, range) 23.85 (1.1-74.6) 13.26 (2-37.9) 
Site   
Supraglottis 70 (75.3%) 14 (63.6%) 
Glottis 20 (21.5%) 5 (22.7%) 
Hypopharynx 3 (3.2%) 3 (13.6%) 
T-stage   
T1 0 (0%) 1 (4.5%) 
T2 3 (3.2%) 2 (9.1%) 
T3 39 (41.9%) 10 (45.5%) 
T4 41 (54.8%) 9 (40.9%) 
N-stage   
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Patient Demographics 
 Training Dataset  
(n=93) 
Testing Dataset  
(n=22) 
N0 33 (35.5%) 8 (36.4%) 
N1 11 (11.8%) 1 (4.5%) 
N2a 2 (2.2%) 0 (0%) 
N2b 22 (23.7%) 4 (18.2%) 
N2c 25 (26.9%) 6 (27.3%) 
N3 0 (0%) 3 (13.6%) 
Median Neutrophil-Lymphocyte Ratio (median, 
range) 2.88 (0.88-56) 2.84 (0.44-10.85) 
Median Lymphocyte-Monocyte Ratio (median, 
range) 1.55 (0.28-5.67) 2.58 (0.70-12.14) 
   
Treatment Information   
Number of days between CT imaging and 
surgeon assessment of response (mean, standard 
deviation) 
1.8 (2.2) 1.1 (0.97) 
Tumor Response (by surgeon assessment)   
<50% 33 (35.5%) 4 (18.2%) 
≥50% 60 (64.5%) 18 (81.8%) 
Average Tumor Reduction by imaging, % 
(standard deviation) 35.45% (34.78%) 55.98% (26.95%) 
Treatment received   
Total laryngectomy 23 (24.7%) 4 (18.2%) 
Chemoradiation 70 (75.3%) 18 (81.8%) 
 
5.2.2 Feature Acquisition and Processing 
Clinical variables were acquired from patient electronic medical records and included tumor site 
label, T-stage, and N-stage.14 Laboratory-based features included neutrophil-lymphocyte ratio 
(NLR) and lymphocyte-monocyte ratio (LMR) calculated from pre-treatment complete blood 
counts. NLR and LMR were incorporated into the models in one of two ways: 1) as log-
transformed, continuous variables or 2) as binary variables determined by cut-points reported 
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previously in literature to have prognostic value for IC outcome in the 9520-patient population.15 
Specifically, NLR variables were set to 0 for NLR values ≤	2.8 and set to 1 otherwise, while LMR 
variables were set to 0 for LMR values ≥ 2.8 and set to 1 otherwise.  
To acquire image-based features, primary gross tumor volume (GTV) structures were 
contoured in pre- and post-IC CT images by experienced radiation oncologists using clinical 
software (Varian Medical Systems, Inc. Eclipse Treatment Planning System). CT-based 
morphological variables investigated were pre-IC primary GTV volume (GTVp) as well as the 
percent reduction in GTV volume between pre and post IC (ΔGTV).  
Radiomic texture features calculated from pre- and post-IC GTV images were also 
included in this study. Using the RADIOMICS toolbox for MATLAB,16 imaging data underwent 
preprocessing, including isotropic resampling to the planar resolution of the CT image and the 
creation of image masks consisting of 3D arrays of 0s and 1s which define the region of interest 
(ROI) specified by the primary GTV contour data.  
First-order texture features were calculated from 64 bin histograms of the gray level image 
data from each ROI. Higher order texture features were calculated using 32 gray-level Lloyd-Max 
quantization. Radiomic features were input into the models as delta radiomics (the difference 
between the radiomic values calculated before and after IC). The 43 radiomics features used for 
this study are summarized in Table 5.2, and a complete description of their definitions and 




Table 5.2: Radiomic imaging features. 
Radiomic Features 
















Gray-Level Run-Length Matrix (GLRLM)  
 Short Run Emphasis (SRE) 
 Long Run Emphasis (LRE) 
 Gray-Level Nonuniformity (GLN) 
 Run-Length Nonuniformity (RLN) 
 Run Percentage (RP) 
 Low Gray-Level Run Emphasis (LGRE) 
 High Gray-Level Run Emphasis (HGRE) 
 Short Run Low Gray-Level Emphasis (SRLGE) 
 Short Run High Gray-Level Emphasis (SRHGE) 
 Long Run Low Gray-Level Emphasis (LRLGE) 
 Long Run High Gray-Level Emphasis (LRHGE) 
 Gray-Level Variance (GLV) 
 Run Length Variance (RLV) 
  
Gray-Level Size Zone Matrix (GLSZM)  
 Small Zone Emphasis (SZE) 
 Large Zone Emphasis (LZE) 
 Gray-Level Nonuniformity (GLN) 
 Zone-Size Nonuniformity (ZSN) 
 Zone Percentage (ZP) 
 Low Gray-Level Zone Emphasis (LGZE) 
 High Gray-Level Zone Emphasis (HGZE) 
 Small Zone Low Gray-Level Emphasis (SZLGE) 
 Small Zone High Gray-Level Emphasis (SZHGE) 
 Large Zone Low Gray-Level Emphasis (LZLGE) 
 Large Zone High Gray-Level Emphasis (LZHGE) 
 Gray-Level Variance (GLV) 
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 Zone Size Variance (ZSV) 
  
Neighbourhood Gray-Tone Difference 







During the later development of the DL models, a decision was made to re-calculate the 
radiomic features using a clinical target volume (CTV) in place of the GTV in order to capture 
additional tumor information from microscopic disease not visible to the human eye. The CTVs 
were defined by adding a 1 cm margin to each primary GTV structure. This was accomplished by 
applying image dilation with a spherical kernel to each ROI. During this process, it was discovered 
that a small subsection of CT images (from 10 patients) contained discrepancies in the metadata 
between different slices of CT scan occurring within the ROI. Specifically, the DICOM attribute, 
image position (patient)—which details the x, y, and z coordinates of the upper left corner of each 
slice in mm—was found in some patient images to vary along an axis that was not the image 
orientation axis. This is believed to have been caused in the situation where patient imaging was 
paused and restarted—resulting in two images being effectively spliced together. While this shift 
appeared to be handled without issue internally by the treatment planning software based on visual 
inspection of the images, it was not communicated during export of the image data to DICOM 
files, resulting in patient structures not lining up correctly across the CT slices. Patients who had 
CT scans with this discrepancy were discarded from the deep learning study because the local 
intensity information of their GTV structures could not be faithfully represented. This resulted in 
the DL models being trained on 83 samples with external testing occurring on 21 samples. 
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5.2.3 Statistical Regression Models Design 
A logistic regression (LR) model18 was used to predict the surgeon-reported ICR, where ICR was 
defined as ≥ 50%	shrinkage of the tumor volume. LR models the log odds for binary outcomes as 




= 	𝛽𝟎 + 𝛽𝟏𝑥𝟏 +	𝛽𝟐𝑥𝟐 +⋯ 5.1 
Where the values, 𝜷 ∈ {𝛽𝟎, 𝛽𝟏, 𝛽𝟐, … } are model parameters which represent the relative 
importance of each feature in 𝒙. From this expression, the probability of event 𝑝	 = 	𝑃(𝑌 = 1|𝒙) 





    5.2 
The values 𝑒W# are referred to as odds ratios and can be used to understand the relative importance 
of each feature 𝑥' to the model. In order to improve model performance, feature selection was 
performed using elastic-net regularization19 and validated using a 3-layer nested cross validation 
(CV) scheme described in Section 5.2.4. The objective function for the regularized LR model is 











¼ + 𝜆 ½
1
2
(1 − 𝛼)‖𝜷‖-- + 𝛼‖𝜷‖$¿J	 5.3 
Where for patient 𝑖, 𝑦' and 𝒙' represent the binary ICR outcome (defined as the surgeon-reported 
tumor response) and the feature vector, respectively; 𝑁 is the total number of patients. The term 
within the first bracket is the negative log likelihood of ICR, and the second term is the elastic-net 
regularization penalty. Elastic-net regularization is a regression method defined as a weighted 
combination of ridge regression and least absolute shrinkage and selection operator (LASSO) 
regression. The parameter 𝜆 represents the regularization penalty, while 𝛼 is a mixing parameter 
which takes a value between 0 and 1 with 𝛼 = 0 representing pure ridge regression and 𝛼 = 1 
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representing pure LASSO regression. For each of the three outcome models, 𝛼 was set to 1 as a 
default. In the event that pure LASSO regression was too parsimonious, 𝛼 was relaxed to allow 
the model to select more features. 
Cox proportional hazards (Cox) models were used to predict LFS and OS, where survival 
times were defined as the time between the pre-induction CT scan and the event of interest. Both 
models were right-censored to time of last follow up. Cox models are survival models that estimate 
the risk of an event occurring at time t as: 
 ℎ(𝑡) = 	ℎ*(𝑡) ∗ exp	(𝜷 ∙ 𝒙) 5.4 
Where ℎ&(𝑡) is a baseline hazard function and 𝜷 is a vector of feature coefficients fit during model 
training and represents the relative importance of each feature in 𝒙.20 The objective function for 
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2
(1 − 𝛼)‖𝜷‖-- + 𝛼‖𝜷‖$¿J	 5.5 
Where 𝑚 represents the total number of unique survival times, 𝒙𝒋 represents a vector of co-variates 
for patient 𝑗, and 𝜷 is a vector of feature coefficients; the index 𝑗(𝑖) represents the index of the 
patient who experienced failure (or was censored) at time, 𝑡'; and 𝑅' represents subset of patient 
indices who are still at risk of failure at time 𝑡'. The first term in the expression is the negative log 
of the Cox partial likelihood—defined as the product of the probabilities of each event at time, i, 
out of m event times given 𝑅' patients at risk of failure at 𝑡'. The second term is the elastic-net 
regularization. As with ICR, feature selection for both OS and LS was implemented via elastic-net 
and the model validated using a 3-layer nested cross validation scheme described in the next 
section. Note that all cross validation used in this study (for both classical and DL models) was 
stratified by outcome. 
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5.2.4 Nested Cross Validation for Feature Selection in Classical Models 
The motivation for using nested cross validation is to avoid introducing bias into the models which 
would lead to overly optimistic performance evaluations.21 In the innermost loop, 10-fold cross 
validation was performed using the cvglmnet() function from the GLMNET package in MATLAB 
to tune the regularization penalty, 𝜆. The optimal 𝜆 was chosen based on the minimal partial 
likelihood loss for the Cox models and the minimal deviance for LR. 
In the middle loop, 10 iterations of 5-fold cross validation were performed to select 
features. Performing multiple iterations of CV was done in order to minimize variance caused by 
sensitivity to how the data is split. For each training fold, the optimal 𝜆 was acquired from the 
innermost loop. The Cox (or LR) model was then fit to the training data. The optimal set of features 
was selected based on which set of features was most frequently selected out of 50 different folds 
and returned to the outer loop.  
In the outermost loop, 10 iterations of 5-fold cross validation were performed to evaluate 
the performance of the model-building method. For each training fold, an optimal feature set was 
returned from the middle loop. A non-regularized Cox or LR model was then trained on these 
features and c-index performance was measured on the test fold. The mean and standard deviations 
of the c-index values across the total of 50 folds was recorded to assess the quality of the model 
building method. 
A final model (i.e., feature set) was obtained by choosing the feature set which appeared 
most frequently in the 50 folds of the outer CV loop. The Cox (or LR) model was then trained on 
the full training dataset using these features and evaluated on the test dataset to assess model 
generalizability. 
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5.2.5 Deep Learning Model Design 
In order to assess potential higher order, nonlinear relationships between covariates and patient 
outcomes, two deep learning models were also developed.  
DeepSurv22 is a Cox proportional hazards deep neural network which was utilized to 
predict OS and LFS outcomes. Recall the expression for the hazard function of the Cox survival 
model given by Equation 5.4 DeepSurv takes advantage of the fact that the expression in the 
exponent, 𝜷 ∙ 𝒙, can be generalized to any unknown function, ℎ(𝜷, 𝒙).20 DeepSurv takes the patient 
features, 𝒙, as inputs and propagates them through a set of fully connected hidden layers, each with 
dropout and non-linear activation function.22 The network’s output consists of a single node, 
ℎb(𝜷, 𝒙), which represents an estimate of the generalized exponential term in the Cox hazard 
function. The networks loss function is similar to that used for the classical implementation of the 
Cox model but uses ridge regularization instead of elastic net: 
 





¼ + 𝜆‖𝜷‖-- 5.6 
Two DeepSurv models were trained to predict OS and LFS outcomes using a 2-layer nested cross 
validation framework, in which the model hyperparameters (regularization penalty, dropout, 
learning rate, number of hidden layers, and number of nodes per hidden layer) were tuned during 
the inner loop of 5-fold CV and model training and validation occurred in the outer loop of 5-fold 
CV. 
A feedforward neural network was designed to predict the probability of ICR outcomes. 
The network took patient features as inputs and, after propagation through a set number of hidden 
layers (each undergoing rectified linear unit [ReLU] activation and dropout), produced an output 
consisting of a single node which was passed through a sigmoid activation function to generate a 
final output between 0 and 1. The model was trained using a binary cross entropy loss function: 
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 𝑙 = 	 (𝑦 ∙ log(𝑥) + (1 − 𝑦) ∙ log	(1 − 𝑥) 5.7 
Similar to DeepSurv, a 2-layer nested cross validation was performed for hyperparameter tuning 
(dropout, learning rate, number of layers, and number of nodes per layer). 
5.3 Results 
5.3.1 Classical Model Results 
Both classical models (Cox and LR) were unable to train when the delta radiomic variables were 
included in the feature set. Tables 5.3 and 5.4 summarize the selected features and model 
performance when the 43 delta radiomics features were excluded from the feature set.  
For the ICR model (implemented through LR), two features were selected through the 
nested-cross validation procedure, ΔGTV and N-stage, with odds ratios (p-values) of 5.78 (<0.001) 
and 1.64 (0.0027) respectively. The ICR model performance was assessed using the area under the 
receiver operating characteristic curve (AUC). The mean AUC was 0.828 (95% CI: 0.803-0.853) 
for cross validation and 0.847 on the external testing dataset. 
For the LFS model (implemented through Cox proportional hazards), a single feature was 
selected through nested cross validation, ΔGTV, with a hazard ratio of 0.58 and a p-value of 
<0.0001. The LFS model performance was assessed using Harrel’s c-index, which was measured 
to be 0.724 (95% CI: 0.699-0.749) during validation and 0.721 on the external testing dataset. An 
additional feature, NLR, was retrospectively identified as contributing significantly to the LFS 
model (p = 0.006) with a hazard ratio of 2.8. However, when this feature was included with ΔGTV, 
the resulting c-index was 0.71 and therefore did not improve the model performance. 
For the OS model (implemented through Cox proportional hazards), two features were 
selected through nested cross validation, GTVp and N-stage, with hazard ratios (p-values) of 1.3 
(0.174) and 1.48 (0.039) respectively. The OS model was evaluated using Harrel’s c-indices, with 
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a mean c-index of 0.601 (95% CI: 0.567-0.635) for cross validation and 0.552 on the external 
testing dataset. 
 
Table 5.3: Feature selection for model building. 
Model Feature Selection 
Model Feature set Odds Ratio P-value 
ICR 
 ΔGTV 5.78 <0.001 
 N-stage 1.64 0.0027 
  Hazard Ratio  
LFS 
 ΔGTV 0.58 <0.0001 
OS 
 GTVp 1.30 0.174 
 N-stage 1.48 0.039 
 
Table 5.4: Classical Model performance. 
Model Performance AUC/Harrel’s C-indices (95% CI range) 
 Cross Validation Testing 
ICR (AUC) 0.828 (0.803-0.853) 0.847 
LFS (c-index) 0.724 (0.699-0.749) 0.721 
OS (c-index) 0.601 (0.567-0.635) 0.552 
 
5.3.2 Deep Learning Model Results 
The DL models were trained on three sets of features—clinical only, radiomics only, and clinical 
+ radiomics—in order to assess whether the radiomics features could be used in complement to or 
in replacement of the clinical features. It was expected that the greater complexity of the deep 
learning models would allow them to train with a greater number of features than the LR and Cox 
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models. This was found to be true to the extent that for all three sets of features, both DL models 
were able learn during model training. However, for all three outcomes (LFS, OS, and ICR), the 
DL models exhibited the best performance when only the clinical features were included. Table 
5.5 summarizes the model performance achieved using DL methods for the clinical features. The  
radiomics features, and combined clinical and radiomics features are also included in Table 5.5 
for completeness. Like the classical models, performance was assessed using Harrel’s c-statistic 
for the survival models and the AUC for the classification model.  
 
Table 5.5: Deep learning model performance. 
Model Performance AUC/Harrel’s C-indices (95% CI range) 
 Cross Validation Testing 
Clinical and Radiomics   
ICR (AUC) 0.522 (0.298-0.745) 0.603 
LFS (c-index) 0.467 (0.367-0.567) 0.625 
OS (c-index) 0.619 (0.420-0.8192) 0.533 
Radiomics Only   
ICR (AUC) 0.525 (0.424-0.625) 0.485 
LFS (c-index) 0.421 (0.336-0.506) 0.58 
OS (c-index) 0.523 (0.375-0.6706) 0.567 
Clinical Only   
ICR (AUC) 0.789 (0.683-0.896) 0.838 
LFS (c-index) 0.674 (0.596-0.752) 0.693 




In this study, we evaluated the use of quantitative, non-invasive features for predicting outcomes 
for laryngeal cancer patients in a bioselection treatment paradigm. Using classical machine 
learning methods, we identified two features (ΔGTV, and N-stage) which contributed significantly 
to the models’ predicted outcome. Given that 30% of patients had discordant results between 
surgeon assessment and actual tumor volume response, it is possible that the number of nodes 
present inadvertently influences the surgeon’s assessment of the primary tumor volume. Our 
results suggest that these features could serve as a quantitative metric in assisting with the decision 
process for patient treatment selection. 
We did not identify any radiomic texture features in this study which could contribute 
positively to model performance. In the case of the classical models, the models were unable to 
learn using the nested cross validation framework when the additional 43 texture features were 
added. For the 3-level nested cross validation scheme, feature selection occurred in the second 
layer over training on 80% of the full training dataset (~75 patients). This challenge was likely due 
to the fact that when the radiomics features were included, the total number of features (50) 
approached the number of training samples during feature selection via LASSO. For the DL 
models, the addition of the radiomics features was found to have a negative impact on model 
performance. These findings suggest that the radiomic features as processed did not play a 
complimentary role to the clinical features. This could be explained by the fact that radiomic 
features have been found to have high correlation with tumor volume.23 
Deep learning methods are particularly attractive for use as predictive models because they 
do not require time-consuming feature engineering and are also capable of modeling complex, 
non-linear relationships between features and outcomes. However, in this study the deep learning 
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models trained using clinical features did not exhibit markedly different performance than the 
classical models and in some cases performed slightly worse. This may suggest that there simply 
wasn’t sufficient training data to overcome model variance.  
One limitation of this study was the small sample size. The original 93 patients used in the 
classical model training were reduced to only 67 for the very inner loop of cross validation. In 
addition, the patient dataset for this study ranged in treatment year from 2003-2019, resulting in 
some patient scans being of lower image quality; this may have impacted the quality and 
robustness of the radiomic features. Finally, there is evidence emerging that advanced imaging 
modalities such as PET, CT perfusion, and MRI hold prognostic value for HCN.24-36 For this study 
we were interested in including data from PET imaging but ultimately were unable to due to the 
low number of PET scans available in the patient datasets. Future studies should aim to increase 
the size of the patient dataset and seek to perform a thorough pre-analysis of radiomic features to 
ensure repeatability and robustness prior to incorporation into the model. 
5.5 Conclusion 
In this study, we investigated the role of CT-based, clinical, and lab features as predictors for OS, 
LFS, and surgeon-assessed response to IC. Initial results indicate that several features investigated 
may have value as predictors for patient outcomes. Due to limited data size, further studies with 
larger datasets are necessary to validate these results and further explore the potential of these 
variables. 
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Chapter 6 Discussion and Future Directives 
 
6.1 Discussion 
In this study, we designed and utilized stochastic and quantum-based algorithms in conjunction 
with classical and deep machine learning algorithms to address challenges in radiation oncology 
related to clinical implementation of image-guided adaptive radiotherapy (ART). To address the 
need for efficient, robust optimization techniques for treatment planning, we developed a quantum-
inspired stochastic optimization algorithm, quantum tunnel annealing (QTA), which models a 
particle tunneling through a one-dimensional potential energy barrier. QTA was found to exhibit 
faster convergence rates than the previously used simulated annealing (SA) across different dose 
constraints and for both beamlet weight and direct aperture optimization. As such, QTA may be a 
promising candidate for optimization scenarios with stronger time constraints such as during 
adaptive replanning.  
ART is a cost- and labor-intensive process which may not provide added benefit for all 
patients.1 Because it is not possible (or clinically necessary) to perform ART for every patient, 
there is a need to develop tools and workflows which can identify which patients stand to benefit 
from ART. We designed and tested two stochastic deep learning frameworks (one quantum-based 
and the other Markov based) for predicting anatomical changes in head and neck cancer patients 
over the course of 30-35 fractions of radiotherapy (RT) treatment. Both algorithms showed 
promising performance in their ability to predict future patient states defined from vector-
quantized distributions of volume changes and couch shifts.  
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Finally, an additional challenge related to ART implementation is that we do not have a full 
understanding of how different individual patient characteristics relate to clinical outcomes. We 
performed a study on laryngeal cancer patients to investigate the use of quantitative, noninvasive 
patient features for predicting patient outcomes as well as predicting clinical decision-making in a 
bioselection treatment paradigm. Our study identified two variables (nodal stage [N-stage] and 
change in primary gross tumor volume [GTV] before and after induction chemotherapy) to 
significantly contribute models predicting laryngectomy free survival and surgeon assessment of 
tumor response. Interestingly, no radiomics features were identified as contributing significantly 
to any of the models developed. 
6.2 Current challenges and limitations 
6.2.1 Data Acquisition, Standardization, and Quantization 
In the era of big data, radiation oncology presents a unique data science challenge in that it contains 
an incredible volume of information on the individual patient level—including radiomic data, 
genomic data, disease classification, dosimetric data, etc.—but patient sample sizes themselves are 
relatively small (on the order of tens to hundreds) whereas other machine learning endeavors 
typically utilize training sample sizes orders of magnitude larger. Particularly for the case of deep 
learning, the property of increased model complexity results in models which are vulnerable to 
fitting noise when the dataset is too small because the deep learning models memorize the training 
dataset rather than learning the true relationship between the data and the output.2 The studies 
presented in this work involving machine learning were limited to patients treated at a single 
institution, and thus training datasets were ultimately limited to a range of 83-125 samples. When 
possible, additional synthetic data was generated to assist with model training; however, efforts 
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being undertaken to make datasets publicly available to medical researchers from multiple 
institutions represent an important task for the future of machine learning in medical physics.3 
 Another challenge associated with data collection in these studies was related to a lack of 
standardization of labeling across patients. These instances tended to be an inherent aspect of the 
clinical workflow. For example, in the study presented in Chapter 4, it was necessary to extract 
the volume information from the primary clinical target volume (CTV) structures of each patient. 
Head and neck cancers typically involve a main tumor structure as well as one or more additional 
nodes, resulting in a primary—as well as secondary or tertiary—CTV structures. In our patient 
data, the contour names assigned to different CTV structures were inconsistent across patients 
because the names chosen by the dosimetrist during the treatment planning were descriptive of the 
unique geometries and/or treatment objectives associated with each patient. Primary CTV labels 
included variations of “CTV High,” “CTV 70,” “CTV Left,” “CTV Right.” Due to ambiguity (it 
is not possible to know whether “CTV Left” or “CTV Right” is the primary or secondary structure), 
it was necessary to manually review each patient’s treatment plan to create a list of keys identifying 
the name of the primary CTV for each patient. In addition, during data processing many patients 
were identified who had multiple cone-beam computed tomography images (CBCTs) acquired on 
the same fraction day. It was important therefore to ensure that only information from the CBCT 
taken immediately prior to the recorded treatment time-stamp was used. However, it was found 
that some patients experienced treatment fractions in which treatment began in one couch position, 
was paused, and then resumed after adjustments. In these instances, such fractions were discarded 
from the training model. These inconsistencies required careful, time-consuming combing of the 
dataset for irregularities. While the original intent of creating medical data is to perform functions 
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related to the clinical workflow, a few simple guidelines to support the standardization of how data 
is recorded could generally save hundreds of hours spent in medical research. 
 Finally, an additional challenge associated with data processing in this study was related 
to the transformation of multivariate, continuous patient data into orthonormal state vectors for the 
quantum and Markov-based recursive neural networks (RNNs). A tradeoff was found between the 
number of potential states that could be encoded in the state vector and the overall model 
performance. During the study, the data input into the model consisted of four variables: volume 
and the x, y, and z values denoting change in table position. Future studies which seek to encode 
more complex or complete descriptions of the patient state (through the inclusion of additional 
features) may require more sophisticated data reduction techniques to adequately capture the 
patient status at each fraction.  
6.2.2 Clinical Implementation 
A key challenge to future clinical implementation for the models presented in this study (and for 
any model used in medical practice) is verification of the accuracy and trustworthiness of the 
model. The need for accuracy can perhaps best be explained by amending the phrase attributed to 
statistician George P. Box: “All models are wrong, but some models (if accurate enough) are 
useful.”4 The need for trustworthiness stems from ethical issues surrounding the use of an 
inanimate algorithm in medical processes in which a human life is at stake. In order for clinicians 
to follow their oath to do no harm, they need to not only be confident in the ability of the tools at 
their disposal but also understand the inner workings of those tools in enough detail to identify 
when a malfunction has occurred. In general, machine learning algorithms suffer from a tradeoff 
between accuracy and interpretability. Due to their complexity, deep learning algorithms, despite 
being the most accurate class of machine learning algorithm, can be characterized as black boxes: 
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we see what is input into the model and what comes out, but exactly how the algorithm reaches its 
decision is difficult to quantify.  
6.3 Future work 
6.3.1 Further Validation and Incorporation of Biological Objectives for QTA 
For the quantum-inspired optimization algorithm featured in Chapter 3, future studies should seek 
to incorporate additional disease locations and treatment modalities (such as brachytherapy) for 
further validation of the model’s capabilities. In addition, it would be interesting to evaluate the 
model’s performance capabilities using more complex, biological optimization objectives 
combining imaging and molecular biomarkers with dose-response functions derived via multiple 
outcome and utility modeling methods.5,6 Finally, if QTA is found to be robust to a variety of 
different radiotherapy applications, it would also be worth exploring its utility as an optimizer for 
training machine learning algorithms. 
6.3.2 Identifying Problem-spaces Tailored to Quantum-based Frameworks 
One challenge in developing quantum-based algorithms is to identify problem spaces in which a 
particular quantum algorithm will achieve higher performance than a classical counterpart.7 In 
Chapter 4, we found that when applied to the task of predicting patient state changes across 
treatment changes, the quantum-based model had slightly lower performance than the Markov-
based model. The quantum model design in this study assumed that the patient states evolved under 
a stationary, real Hamiltonian and that no measurements were made on the state during the course 
of treatment. (Note that the assumption that no measurements were made on the patient’s “system 
state” during treatment was made because changes in structure volume were not explicitly 
measured during treatment from CBCT data.) There are a few interesting modifications that could 
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be made to this framework which could result in advanced performance for the quantum model. 
The first would be to take into account potential measurements on the patient system, which would 
result in a change or “collapse” of the quantum wave state. Such measurements could be defined 
as instances in which the patient undergoes additional computed tomography (CT) scanning 
partway through their treatment (a phenomenon which was noted to have occurred for many 
patients in our dataset, likely to assess their anatomical response to treatment). In addition, at the 
time of implementation, the deep learning library utilized (PyTorch) was not yet fully able to 
handle complex values within the backpropagation function. This meant that we were required to 
define our Hamiltonian as a real-valued matrix, reducing the potential solution space. Given that 
complex functions have been an area of active development for PyTorch as of 2020, it would be 
interesting in the near future to assess the performance of the quantum model when the 
Hamiltonian is allowed (more realistically) to contain any value in the complex plane. 
6.3.3 Incorporation of PET-CT and Identification of Robust Features 
In Chapter 5, we did not include positron emission tomography (PET) imaging data into our model 
because of a lack of available PET images in the patient dataset. However, PET radiomics features 
have been shown to have some prognostic value for head and neck cancer outcomes.8-10 For future 
studies it would be helpful to curate additional patients into our current dataset with a focus on 
those who have PET imaging available so that these variables can be assessed under the 
bioselection paradigm. Finally, given that a portion of the CT radiomics in this study came from 
older, lower quality scans, future studies might benefit from performing additional analysis to 
identify the subset of radiomic features which are robust to variations in image quality or other 
imaging parameters such as reconstructions settings.11 
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